LyondellBasell Industries (LYB) 10-Q 28 Oct 22 2022 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	9 Months Ended
	Sep. 30, 2022	Oct. 26, 2022
Document And Entity Information [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Sep. 30, 2022
Document Transition Report	false
Entity File Number	001-34726
Entity Registrant Name	LYONDELLBASELL INDUSTRIES N.V.
Entity Incorporation, State or Country Code	P7
Entity Tax Identification Number	98-0646235
Title of 12(b) Security	Ordinary Shares, €0.04 Par Value
Trading Symbol	LYB
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		325,624,433
Entity Central Index Key	0001489393
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	Q3
Amendment Flag	false
Entity Addresses [Line Items]
Entity Address, Address Line One	1221 McKinney St.,
Entity Address, Address Line Two	Suite 300
Entity Address, City or Town	Houston,
Entity Address, State or Province	TX
Entity Address, Country	US
Entity Address, Postal Zip Code	77010
City Area Code	(713)
Local Phone Number	309-7200
United Kingdom [Member]
Entity Addresses [Line Items]
Entity Address, Address Line One	4th Floor, One Vine Street
Entity Address, City or Town	London
Entity Address, Country	GB
Entity Address, Postal Zip Code	W1J0AH
Country Region	+44 (0)
City Area Code	207
Local Phone Number	220 2600
Netherlands [Member]
Entity Addresses [Line Items]
Entity Address, Address Line One	Delftseplein 27E
Entity Address, City or Town	Rotterdam
Entity Address, Country	NL
Entity Address, Postal Zip Code	3013AA
Country Region	+31 (0)
City Area Code	10
Local Phone Number	2755 500

Consolidated Statements of Inco

Consolidated Statements of Income - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Sales and other operating revenues:
Trade	$ 12,044	$ 12,401	$ 39,443	$ 32,586
Related parties	206	299	802	757
Sales revenue, net	12,250	12,700	40,245	33,343
Operating costs and expenses:
Cost of sales	11,088	10,109	34,491	26,463
Impairments	0	0	69	0
Selling, general and administrative expenses	319	313	976	927
Research and development expenses	31	30	95	91
Costs and expenses	11,438	10,452	35,631	27,481
Operating income	812	2,248	4,614	5,862
Interest expense	(70)	(126)	(202)	(366)
Interest income	7	1	13	8
Other income (expense), net	4	(12)	(63)	27
Income from continuing operations before equity investments and income taxes	753	2,111	4,362	5,531
(Loss) income from equity investments	(26)	104	25	389
Income from continuing operations before income taxes	727	2,215	4,387	5,920
Provision for income taxes	154	452	848	1,028
Income from continuing operations	573	1,763	3,539	4,892
Loss from discontinued operations, net of tax	(1)	(1)	(3)	(1)
Net income	572	1,762	3,536	4,891
Dividends on redeemable non-controlling interests	(2)	(2)	(5)	(5)
Net income attributable to the Company shareholders	$ 570	$ 1,760	$ 3,531	$ 4,886
Net income (loss) attributable to the Company shareholders - Basic:
Continuing operations (in dollars per share)	$ 1.75	$ 5.25	$ 10.77	$ 14.58
Discontinued operations (in dollars per share)	0	0	(0.01)	0
Basic (in dollars per share)	1.75	5.25	10.76	14.58
Net income (loss) attributable to the Company shareholders - Diluted:
Continuing operations (in dollars per share)	1.75	5.25	10.75	14.57
Discontinued operations (in dollars per share)	0	0	(0.01)	0
Diluted (in dollars per share)	$ 1.75	$ 5.25	$ 10.74	$ 14.57

Consolidated Statements of Comp

Consolidated Statements of Comprehensive Income - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Net income	$ 572	$ 1,762	$ 3,536	$ 4,891
Other comprehensive income (loss), net of tax –
Financial derivatives	23	35	213	132
Unrealized losses on available-for-sale debt securities	0	0	0	(1)
Defined benefit pension and other postretirement benefit plans	51	28	134	56
Foreign currency translations	(169)	(97)	(355)	(127)
Total other comprehensive (loss) income, net of tax	(95)	(34)	(8)	60
Comprehensive income	477	1,728	3,528	4,951
Dividends on redeemable non-controlling interests	(2)	(2)	(5)	(5)
Comprehensive income attributable to the Company shareholders	$ 475	$ 1,726	$ 3,523	$ 4,946

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($) $ in Millions	Sep. 30, 2022	Dec. 31, 2021
Current assets:
Cash and cash equivalents	$ 1,480	$ 1,472
Restricted cash	6	5
Short-term investments	0	9
Accounts receivable:
Trade, net	4,149	4,565
Related parties	180	243
Inventories	5,153	4,901
Prepaid expenses and other current assets	1,360	1,022
Total current assets	12,328	12,217
Operating lease assets	1,769	1,946
Property, plant and equipment	22,640	22,382
Less: Accumulated depreciation	(7,817)	(7,826)
Property, plant and equipment, net	14,823	14,556
Equity investments	4,386	4,786
Goodwill	1,746	1,875
Intangible assets, net	594	695
Other assets	845	667
Total assets	36,491	36,742
Current liabilities:
Current maturities of long-term debt	432	6
Short-term debt	439	362
Accounts payable:
Trade	3,508	3,460
Related parties	622	831
Accrued liabilities	2,633	2,571
Total current liabilities	7,634	7,230
Long-term debt	10,445	11,246
Operating lease liabilities	1,514	1,649
Other liabilities	2,106	2,295
Deferred income taxes	2,473	2,334
Commitments and contingencies
Redeemable non-controlling interests	114	116
Shareholders’ equity:
Ordinary shares, €0.04 par value, 1,275 million shares authorized, 325,623,082 and 329,536,389 shares outstanding, respectively	19	19
Additional paid-in capital	6,099	6,044
Retained earnings	9,232	8,563
Accumulated other comprehensive loss	(1,811)	(1,803)
Treasury stock, at cost, 14,799,416 and 10,675,605 ordinary shares, respectively	(1,348)	(965)
Total Company share of shareholders’ equity	12,191	11,858
Non-controlling interests	14	14
Total equity	12,205	11,872
Total liabilities, redeemable non-controlling interests and equity	$ 36,491	$ 36,742

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parentheticals) - € / shares	Sep. 30, 2022	Dec. 31, 2021
Shareholders’ equity:
Ordinary shares par value (in euros per share)	€ 0.04	€ 0.04
Ordinary shares, shares authorized (in shares)	1,275,000,000	1,275,000,000
Ordinary shares, shares outstanding (in shares)	325,623,082	329,536,389
Treasury stock, shares (in shares)	14,799,416	10,675,605

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Cash flows from operating activities:
Net income	$ 3,536	$ 4,891
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	933	1,016
Impairments	69	0
Amortization of debt-related costs	11	21
Share-based compensation	54	50
Equity investments -
Equity income	(25)	(389)
Distributions of earnings, net of tax	219	169
Deferred income tax provision	83	7
Changes in assets and liabilities that provided (used) cash:
Accounts receivable	134	(1,915)
Inventories	(601)	(741)
Accounts payable	200	1,139
Other, net	(98)	368
Net cash provided by operating activities	4,515	4,616
Cash flows from investing activities:
Expenditures for property, plant and equipment	(1,417)	(1,285)
Proceeds from maturities of available-for-sale debt securities	0	346
Proceeds from equity securities	8	309
Acquisition of equity method investment	(14)	(104)
Proceeds from settlement of net investment hedges	614	358
Payments for settlement of net investment hedges	(501)	(355)
Other, net	(123)	(66)
Net cash used in investing activities	(1,433)	(797)
Cash flows from financing activities:
Repurchases of Company ordinary shares	(420)	(78)
Dividends paid - common stock	(2,859)	(1,110)
Repayments of long-term debt	0	(2,275)
Debt extinguishment costs	0	(57)
Net proceeds from (repayments of) commercial paper	96	(103)
Collateral received from interest rate derivatives	238	0
Other, net	16	(4)
Net cash used in financing activities	(2,929)	(3,627)
Effect of exchange rate changes on cash	(144)	(59)
Increase in cash and cash equivalents and restricted cash	9	133
Cash and cash equivalents and restricted cash at beginning of period	1,477	1,765
Cash and cash equivalents and restricted cash at end of period	$ 1,486	$ 1,898

Consolidated Statements of Shar

Consolidated Statements of Shareholders' Equity - USD ($) $ in Millions	Total	Ordinary Shares	Treasury Stock	Additional Paid-in Capital	Retained Earnings	Accumulated Other Comprehensive Loss	Company Share of Shareholders' Equity	Non-Controlling Interests
Beginning balance at Dec. 31, 2020		$ 19	$ (531)	$ 5,986	$ 4,440	$ (1,943)	$ 7,971	$ 17
Net income	$ 4,891	0	0	0	4,891	0	4,891	0
Other comprehensive income (loss)	60	0	0	0	0	60	60	0
Share-based compensation		0	39	43	0	0	82	0
Dividends - common stock		0	0	0	(1,110)	0	(1,110)	0
Dividends - redeemable non-controlling interests	(5)	0	0	0	(5)	0	(5)	0
Repurchases of Company ordinary shares		0	(89)	0	0	0	(89)	0
Sales of non-controlling interest		0	0	0	0	0	0	(3)
Ending balance at Sep. 30, 2021		19	(581)	6,029	8,216	(1,883)	11,800	14
Beginning balance at Jun. 30, 2021		19	(494)	6,011	6,837	(1,849)	10,524	14
Net income	1,762	0	0	0	1,762	0	1,762	0
Other comprehensive income (loss)	(34)	0	0	0	0	(34)	(34)	0
Share-based compensation		0	2	18	(1)	0	19	0
Dividends - common stock		0	0	0	(380)	0	(380)	0
Dividends - redeemable non-controlling interests	(2)	0	0	0	(2)	0	(2)	0
Repurchases of Company ordinary shares		0	(89)	0	0	0	(89)	0
Ending balance at Sep. 30, 2021		19	(581)	6,029	8,216	(1,883)	11,800	14
Beginning balance at Dec. 31, 2021	11,872	19	(965)	6,044	8,563	(1,803)	11,858	14
Net income	3,536	0	0	0	3,536	0	3,536	0
Other comprehensive income (loss)	(8)	0	0	0	0	(8)	(8)	0
Share-based compensation		0	23	55	(3)	0	75	0
Dividends - common stock		0	0	0	(1,155)	0	(1,155)	0
Special dividends - common stock		0	0	0	(1,704)	0	(1,704)	0
Dividends - redeemable non-controlling interests	(5)	0	0	0	(5)	0	(5)	0
Repurchases of Company ordinary shares	(406)	0	(406)	0	0	0	(406)	0
Ending balance at Sep. 30, 2022	12,205	19	(1,348)	6,099	9,232	(1,811)	12,191	14
Beginning balance at Jun. 30, 2022		19	(1,200)	6,077	9,050	(1,716)	12,230	14
Net income	572	0	0	0	572	0	572	0
Other comprehensive income (loss)	(95)	0	0	0	0	(95)	(95)	0
Share-based compensation		0	2	22	7	0	31	0
Dividends - common stock		0	0	0	(395)	0	(395)	0
Dividends - redeemable non-controlling interests	(2)	0	0	0	(2)	0	(2)	0
Repurchases of Company ordinary shares		0	(150)	0	0	0	(150)	0
Ending balance at Sep. 30, 2022	$ 12,205	$ 19	$ (1,348)	$ 6,099	$ 9,232	$ (1,811)	$ 12,191	$ 14

Consolidated Statements of Sh_2

Consolidated Statements of Shareholders' Equity (Parentheticals) - $ / shares	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Statement of Stockholders' Equity [Abstract]
Common stock, dividends per share (in dollars per share)	$ 1.19	$ 1.13	$ 3.51	$ 3.31
Common stock, special dividends per share (in dollars per share)			5.20
Redeemable non-controlling interests, dividends per share (in dollars per share)	$ 15	$ 15	$ 45	$ 45

Basis of Presentation

Basis of Presentation	9 Months Ended
	Sep. 30, 2022
Disclosure Text Block [Abstract]
Basis of Presentation [Text Block]	1. Basis of Presentation LyondellBasell Industries N.V. is a limited liability company (Naamloze Vennootschap) incorporated under Dutch law by deed of incorporation dated October 15, 2009. Unless otherwise indicated, the “Company,” “we,” “us,” “our” or similar words are used to refer to LyondellBasell Industries N.V. together with its consolidated subsidiaries (“LyondellBasell N.V.”). LyondellBasell N.V. is a worldwide manufacturer of chemicals and polymers, a refiner of crude oil, a significant producer of gasoline blending components and a developer and licensor of technologies for the production of polymers. The accompanying unaudited Consolidated Financial Statements have been prepared from the books and records of LyondellBasell N.V. in accordance with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X for interim financial information. Certain notes and other information have been condensed or omitted from the interim financial statements included in this report. Accordingly, they do not include all of the information and notes required by accounting principles generally accepted in the United States (“U.S. GAAP”) for complete financial statements. These Consolidated Financial Statements should be read in conjunction with the Consolidated Financial Statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021. In the opinion of management, all adjustments, including normal recurring adjustments, considered necessary for a fair statement have been included. These statements contain some amounts that are based upon management estimates and judgments. Future actual results could differ from such current estimates. The results for interim periods are not necessarily indicative of results for the entire year.

Accounting and Reporting Change

Accounting and Reporting Changes	9 Months Ended
	Sep. 30, 2022
Accounting Changes and Error Corrections [Abstract]
Accounting and Reporting Changes [Text Block]	2. Accounting and Reporting Changes Recently Adopted Guidance There were no new standards or Accounting Standard Updates (“ASU”) adopted during the nine months ended September 30, 2022 that had a material impact on our Consolidated Financial Statements. Accounting Guidance Issued But Not Adopted as of September 30, 2022 Government Assistance—In November 2021, the Financial Accounting Standards Board (“FASB”) issued ASU 2021-10, Government Assistance (Topic 832): Disclosures by Business Entities about Government Assistance. The guidance requires disclosures about assistance received from the government that have been accounted for by analogizing to a grant or contribution accounting model including the nature and form of assistance, the accounting policies used to account for the assistance and its impact on the entity’s financial statements. The guidance is effective for annual periods beginning after December 15, 2021, with early adoption permitted. The adoption of this guidance will not have a material impact on our Consolidated Financial Statements. Fair Value Measurement—In June 2022, the FASB issued ASU 2022-03, Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions. The guidance clarifies that a contractual restriction on the sale of an equity security is not considered part of the unit of account of the equity security because it is a characteristic of the entity holding the equity security rather than a characteristic of the security and is not considered in measuring its fair value. The guidance is effective prospectively for the year ending December 31, 2024 including the interim periods, with the impact of adoption reflected in earnings. Early adoption is permitted. The adoption of this guidance will not have a material impact on our Consolidated Financial Statements. Supplier Finance Program—In September 2022, the FASB issued ASU 2022-04, Liabilities—Supplier Finance Programs (Subtopic 405-50): Disclosure of Supplier Finance Program Obligations. The guidance requires an entity that uses supplier finance programs in connection with the purchase of goods and services to disclose certain qualitative and quantitative information about its programs including the key terms and conditions, activity during the period, and potential magnitude. The guidance is effective retrospectively for the year ending December 31, 2023, including interim periods, with disclosures required for each period for which a balance sheet is presented, except for the disclosure of roll forward information, which is effective for fiscal years beginning after December 15, 2023. We are in the process of the assessing the impact of the new guidance on our Consolidated Financial Statements.

Revenues

Revenues	9 Months Ended
	Sep. 30, 2022
Revenue from Contract with Customer [Abstract]
Revenues [Text Block]	3. Revenues Contract Balances— Contract liabilities were $179 million and $169 million at September 30, 2022 and December 31, 2021, respectively. Revenue recognized in each reporting period, included in the contract liability balance at the beginning of the period, was immaterial. Disaggregation of Revenues— The following table presents our revenues disaggregated by key products: Three Months Ended Nine Months Ended Millions of dollars 2022 2021 2022 2021 Sales and other operating revenues: Olefins and co-products $ 1,281 $ 1,453 $ 3,835 $ 3,729 Polyethylene 2,306 2,705 7,714 7,469 Polypropylene 1,466 2,162 5,383 5,876 Propylene oxide and derivatives 721 832 2,537 2,059 Oxyfuels and related products 1,563 1,088 4,370 2,533 Intermediate chemicals 917 910 3,228 2,436 Compounding and solutions 1,049 1,019 3,297 3,134 Advanced polymers 245 261 827 748 Refined products 2,506 2,050 8,467 4,784 Other 196 220 587 575 Total $ 12,250 $ 12,700 $ 40,245 $ 33,343 The following table presents our revenues disaggregated by geography, based upon the location of the customer: Three Months Ended Nine Months Ended Millions of dollars 2022 2021 2022 2021 Sales and other operating revenues: United States $ 5,966 $ 6,387 $ 19,465 $ 16,089 Germany 822 886 2,892 2,585 China 647 572 1,989 1,693 Japan 800 432 1,684 993 Mexico 482 496 1,522 1,133 Italy 387 489 1,426 1,339 France 312 384 1,145 1,040 Poland 270 300 1,039 841 The Netherlands 261 423 995 1,039 Other 2,303 2,331 8,088 6,591 Total $ 12,250 $ 12,700 $ 40,245 $ 33,343

Accounts Receivable

Accounts Receivable	9 Months Ended
	Sep. 30, 2022
Receivables [Abstract]
Accounts Receivable [Text Block]	4. Accounts Receivable Our accounts receivable are reflected in the Consolidated Balance Sheets, net of allowance for credit losses of $5 million and $6 million as of September 30, 2022 and December 31, 2021, respectively.

Inventories

Inventories	9 Months Ended
	Sep. 30, 2022
Inventory Disclosure [Abstract]
Inventories [Text Block]	5. Inventories Inventories consisted of the following components: Millions of dollars September 30, December 31, Finished goods $ 3,287 $ 3,329 Work-in-process 184 178 Raw materials and supplies 1,682 1,394 Total inventories $ 5,153 $ 4,901

Debt

Debt	9 Months Ended
	Sep. 30, 2022
Debt Disclosure [Abstract]
Debt [Text Block]	6. Debt Long-term loans, notes and other debt, net of unamortized discount and debt issuance cost, consisted of the following: Millions of dollars September 30, December 31, Senior Notes due 2024, $1,000 million, 5.75% ($1 million of debt issuance cost) $ 774 $ 773 Senior Notes due 2055, $1,000 million, 4.625% ($15 million of discount; $11 million of debt issuance cost) 974 974 Guaranteed Notes due 2027, $300 million, 8.1% 300 300 Issued by LYB International Finance B.V.: Guaranteed Notes due 2023, $750 million, 4.0% ($1 million of discount) 424 423 Guaranteed Notes due 2043, $750 million, 5.25% ($19 million of discount; $6 million of debt issuance cost) 725 724 Guaranteed Notes due 2044, $1,000 million, 4.875% ($10 million of discount; $9 million of debt issuance cost) 981 981 Issued by LYB International Finance II B.V.: Guaranteed Notes due 2026, €500 million, 0.875% ($1 million of discount; $2 million of debt issuance cost) 474 562 Guaranteed Notes due 2027, $1,000 million, 3.5% ($3 million of discount; $2 million of debt issuance cost) 588 631 Guaranteed Notes due 2031, €500 million, 1.625% ($4 million of discount; $3 million of debt issuance cost) 471 558 Issued by LYB International Finance III LLC: Guaranteed Notes due 2025, $500 million, 1.25% ($1 million of discount; $2 million of debt issuance cost) 475 486 Guaranteed Notes due 2030, $500 million, 3.375% ($1 million of debt issuance cost) 119 143 Guaranteed Notes due 2030, $500 million, 2.25% ($3 million of discount; $4 million of debt issuance cost) 468 490 Guaranteed Notes due 2040, $750 million, 3.375% ($2 million of discount; $7 million of debt issuance cost) 741 741 Guaranteed Notes due 2049, $1,000 million, 4.2% ($14 million of discount; $10 million of debt issuance cost) 976 975 Guaranteed Notes due 2050, $1,000 million, 4.2% ($6 million of discount; $10 million of debt issuance cost) 971 981 Guaranteed Notes due 2051, $1,000 million, 3.625% ($2 million of discount; $11 million of debt issuance cost) 892 986 Guaranteed Notes due 2060, $500 million, 3.8% ($4 million of discount; $6 million of debt issuance cost) 480 490 Other 44 34 Total 10,877 11,252 Less current maturities (432) (6) Long-term debt $ 10,445 $ 11,246 Fair value hedging adjustments associated with the fair value hedge accounting of our fixed-for-floating interest rate swaps for the applicable periods are as follows: Gains (Losses) Cumulative Fair Value Three Months Ended Nine Months Ended September 30, December 31, Millions of dollars 2022 2021 2022 2021 2022 2021 Guaranteed Notes due 2025, 1.25% $ 3 $ 1 $ 12 $ 1 $ 14 $ 2 Guaranteed Notes due 2026, 0.875% 3 1 10 2 11 1 Guaranteed Notes due 2027, 3.5% 15 5 44 12 (2) (46) Guaranteed Notes due 2030, 3.375% 8 1 24 (3) 22 (2) Guaranteed Notes due 2030, 2.25% 7 1 23 1 25 2 Guaranteed Notes due 2031, 1.625% 7 — 10 — 10 — Guaranteed Notes due 2050, 4.2% 5 1 10 1 13 3 Guaranteed Notes due 2051, 3.625% 41 — 95 — 95 — Guaranteed Notes due 2060, 3.8% 8 — 10 — 10 — Total $ 97 $ 10 $ 238 $ 14 $ 198 $ (40) Fair value adjustments are recognized in Interest expense in the Consolidated Statements of Income. Short-term loans, notes and other debt consisted of the following: Millions of dollars September 30, December 31, U.S. Receivables Facility $ — $ — Commercial paper 300 204 Precious metal financings 131 155 Other 8 3 Total Short-term debt $ 439 $ 362 Long-Term Debt Senior Revolving Credit Facility —Our $3,250 million Senior Revolving Credit Facility, which expires in November 2026, may be used for dollar and euro denominated borrowings. The facility has a $200 million sub-limit for dollar and euro denominated letters of credit, a $1,000 million uncommitted accordion feature and supports our commercial paper program. Borrowings under the facility bear interest at either a base rate, LIBOR rate or EURIBOR rate, plus an applicable margin. Additional fees are incurred for the average daily unused commitments. At September 30, 2022, we had no borrowings or letters of credit outstanding and $2,950 million of unused availability under this facility. Short-Term Debt U.S. Receivables Facility —Our U.S. Receivables Facility, which expires in June 2024, has a purchase limit of $900 million in addition to a $300 million uncommitted accordion feature. This facility provides liquidity through the sale or contribution of trade receivables by certain of our U.S. subsidiaries to a wholly owned, bankruptcy-remote subsidiary on an ongoing basis and without recourse. We pay variable interest rates on our secured borrowings. Additional fees are incurred for the average daily unused commitments. This facility also provides for the issuance of letters of credit up to $200 million. At September 30, 2022, we had no borrowings or letters of credit outstanding and $900 million unused availability under this facility. Commercial Paper Program —We have a commercial paper program under which we may issue up to $2,500 million of privately placed, unsecured, short-term promissory notes (“commercial paper”). Interest rates on commercial paper outstanding are based on the terms of the notes and was 3.35% at September 30, 2022. At September 30, 2022, we had $300 million of outstanding commercial paper. Weighted Average Interest Rate —At September 30, 2022 and December 31, 2021, our weighted average interest rates on outstanding Short-term debt were 3.0% and 0.9%, respectively. Additional Information Debt Discount and Issuance Costs —Amortization of debt discounts and debt issuance costs resulted in amortization expense of $11 million and $21 million for the nine months ended September 30, 2022 and 2021, respectively, which is included in Interest expense in the Consolidated Statements of Income. As of September 30, 2022, we are in compliance with our debt covenants.

Financial Instruments and Fair

Financial Instruments and Fair Value Measurements	9 Months Ended
	Sep. 30, 2022
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Financial Instruments and Fair Value Measurements [Text Block]	7. Financial Instruments and Fair Value Measurements We are exposed to market risks, such as changes in commodity pricing, interest rates and currency exchange rates. To manage the volatility related to these exposures, we selectively enter into derivative contracts pursuant to our risk management policies. Financial Instruments Measured at Fair Value on a Recurring Basis —The following table summarizes financial instruments outstanding for the periods presented that are measured at fair value on a recurring basis: September 30, 2022 December 31, 2021 Millions of dollars Notional Amount Fair Value Notional Amount Fair Value Balance Sheet Assets– Derivatives designated as hedges: Commodities $ 35 $ 15 $ 41 $ 24 Prepaid expenses and other current assets Foreign currency 612 144 614 63 Prepaid expenses and other current assets Foreign currency 3,666 396 1,785 43 Other assets Interest rates — 26 — 7 Prepaid expenses and other current assets Interest rates 400 16 300 1 Other assets Derivatives not designated as hedges: Commodities 160 14 221 30 Prepaid expenses and other current assets Commodities 2 — — — Other assets Foreign currency 318 5 34 1 Prepaid expenses and other current assets Non-derivatives: Equity securities — — 9 8 Short-term investments Total $ 5,193 $ 616 $ 3,004 $ 177 Liabilities– Derivatives designated as hedges: Commodities $ 43 $ 4 $ — $ — Accrued liabilities Foreign currency — 23 — 14 Accrued liabilities Foreign currency — — 1,800 99 Other liabilities Interest rates — 15 — 3 Accrued liabilities Interest rates 2,145 237 1,863 280 Other liabilities Derivatives not designated as hedges: Commodities 101 19 24 1 Accrued liabilities Commodities 7 — — — Other liabilities Foreign currency 87 1 188 2 Accrued liabilities Total $ 2,383 $ 299 $ 3,875 $ 399 The financial instruments in the table above are classified as Level 2. We present the gross assets and liabilities of our derivative financial instruments on the Consolidated Balance Sheets. Financial Instruments Not Measured at Fair Value on a Recurring Basis —The following table presents the carrying value and estimated fair value of our Short-term precious metal financings and Long-term debt: September 30, 2022 December 31, 2021 Millions of dollars Carrying Fair Carrying Fair Precious metal financings $ 131 $ 126 $ 155 $ 130 Long-term debt 10,420 9,025 11,218 12,756 Total $ 10,551 $ 9,151 $ 11,373 $ 12,886 The financial instruments in the table above are classified as Level 2. Our other financial instruments classified within Current assets and Current liabilities have a short maturity and their carrying value generally approximates fair value. Derivative Instruments: Commodity Prices —The following table presents the notional amounts of our outstanding commodity derivative instruments: September 30, 2022 December 31, 2021 Millions of dollars Notional Amount Notional Amount Maturity Date Derivatives designated as hedges: Cash flow hedges $ 78 $ 41 2022 to 2023 Derivatives not designated as hedges: Commodity contracts 270 245 2022 to 2024 Interest Rates —The following table presents the notional amounts of our outstanding interest rate derivative instruments: September 30, 2022 December 31, 2021 Millions of dollars Notional Amount Notional Amount Maturity Date Cash flow hedges $ 400 $ 1,000 2024 Fair value hedges 2,145 1,163 2025 to 2031 As of December 31, 2021, Other assets included $238 million of collateral related to forward-starting interest swaps. As of September 30, 2022, there was no collateral remaining as it had been returned. Foreign Currency Rates —The following table presents the notional amounts of our outstanding foreign currency derivative instruments: September 30, 2022 December 31, 2021 Millions of dollars Notional Amount Notional Amount Maturity Date Net investment hedges $ 3,128 $ 3,048 2023 to 2030 Cash flow hedges 1,150 1,150 2024 to 2027 Not designated 405 222 2022 to 2023 Impact on Earnings and Other Comprehensive Income —The following tables summarize the pre-tax effect of derivative instruments recorded in Accumulated other comprehensive loss (“AOCI”), the gains (losses) reclassified from AOCI to earnings and additional gains (losses) recognized directly in earnings: Effects of Financial Instruments Three Months Ended September 30, Balance Sheet Income Statement Gain (Loss) Gain (Loss) Reclassified Additional Gain Income Statement Millions of dollars 2022 2021 2022 2021 2022 2021 Classification Derivatives designated as hedges: Commodities $ 10 $ 38 $ (22) $ (14) $ — $ — Cost of sales Foreign currency 285 135 (67) (60) 20 9 Interest expense Interest rates 29 17 1 1 (94) (5) Interest expense Derivatives not designated as hedges: Commodities — — — — (16) 6 Sales and other operating revenues Commodities — — — — (28) 49 Cost of sales Foreign currency — — — — (15) (32) Other income (expense), net Total $ 324 $ 190 $ (88) $ (73) $ (133) $ 27 Effects of Financial Instruments Nine Months Ended September 30, Balance Sheet Income Statement Gain (Loss) Gain (Loss) Reclassified Additional Gain Income Statement Millions of dollars 2022 2021 2022 2021 2022 2021 Classification Derivatives designated as hedges: Commodities $ 40 $ 67 $ (54) $ (18) $ — $ — Cost of sales Foreign currency 607 274 (169) (128) 51 34 Interest expense Interest rates 287 117 4 4 (221) — Interest expense Derivatives not designated as hedges: Commodities — — — — 66 18 Sales and other operating revenues Commodities — — — — (17) 72 Cost of sales Foreign currency — — — — (54) (61) Other income (expense), net Total $ 934 $ 458 $ (219) $ (142) $ (175) $ 63 As of September 30, 2022, on a pre-tax basis, $6 million is scheduled to be reclassified from Accumulated other comprehensive loss as an increase to Interest expense over the next twelve months. Other Financial Instruments: Cash and Cash Equivalents —At September 30, 2022 and December 31, 2021, we had marketable securities classified as Cash and cash equivalents of $1,075 million and $438 million, respectively.

Pension Benefits

Pension Benefits	9 Months Ended
	Sep. 30, 2022
Retirement Benefits [Abstract]
Pension Benefits [Text Block]	8. Pension Benefits Components of net periodic pension costs for our U.S. and non-U.S. plans are as follows: U.S. Plans Three Months Ended Nine Months Ended Millions of dollars 2022 2021 2022 2021 Service cost $ 11 $ 15 $ 37 $ 45 Interest cost 13 9 34 26 Expected return on plan assets (20) (28) (77) (82) Settlement loss 6 20 100 24 Actuarial loss amortization 4 8 16 29 Net periodic benefit costs $ 14 $ 24 $ 110 $ 42 Non-U.S. Plans Three Months Ended Nine Months Ended Millions of dollars 2022 2021 2022 2021 Service cost $ 9 $ 11 $ 28 $ 33 Interest cost 7 5 21 16 Expected return on plan assets (5) (4) (15) (12) Prior service amortization 2 1 3 2 Actuarial loss amortization 2 4 6 12 Net periodic benefit costs $ 15 $ 17 $ 43 $ 51 The components of net periodic benefit cost other than the service cost component are included in Other income (expense), net in the Consolidated Statements of Income. In May 2022, a LyondellBasell sponsored pension plan purchased a group annuity contract from an insurance company to transfer $361 million of our outstanding pension benefit obligations related to certain U.S. retirees and beneficiaries. The purchase of the group annuity contract was funded with pension plan assets. The insurance company is now required to pay and administer the retirement benefits owed to approximately 9,000 U.S. retirees and beneficiaries with no change to their monthly retirement benefit payment amounts. In connection with this transaction, in the second quarter of 2022, we recognized a non-cash pension settlement loss of $80 million, reflected in Other income (expense), net, primarily related to the accelerated recognition of actuarial losses included in Accumulated other comprehensive loss.

Income Taxes

Income Taxes	9 Months Ended
	Sep. 30, 2022
Income Tax Disclosure [Abstract]
Income Taxes [Text Block]	9. Income Taxes For interim tax reporting, we estimate an annual effective tax rate which is applied to the year-to-date ordinary income. Tax effects of significant unusual or infrequently occurring items are excluded from the estimated annual effective tax rate calculation and recognized in the interim period in which they occur. Our effective income tax rate fluctuates based on, among other factors, changes in pre-tax income in countries with varying statutory tax rates, changes in valuation allowances, changes in foreign exchange gains or losses, the amount of exempt income, changes in unrecognized tax benefits associated with uncertain tax positions and changes in tax laws. Our exempt income primarily includes interest income, export incentives, and equity earnings of joint ventures. Interest income earned by certain of our European subsidiaries through intercompany financings is taxed at rates substantially lower than the U.S. statutory rate. Export incentives relate to tax benefits derived from elections and structures available for U.S. exports. Equity earnings attributable to the earnings of our joint ventures, when paid through dividends to certain European subsidiaries, are exempt from all or portions of normal statutory income tax rates. We currently anticipate the favorable treatment for interest income, dividends, and export incentives to continue in the near term; however, this treatment is based on current law and tax rulings, which could change if certain legislative changes are enacted, including Pillar Two proposals by the Organization for Economic Cooperation and Development (“OECD”). On August 16, 2022, the U.S. enacted the Inflation Reduction Act (“IRA”) which is intended to address climate change, lower health-care costs and reduce the federal deficit. We are continuing to analyze the provisions included in the IRA; however we do not expect it to have a material impact on our Consolidated Financial Statements. Our effective income tax rate for the third quarter of 2022 was 21.2% compared with 20.4% for the third quarter of 2021. The higher effective tax rate for the third quarter of 2022 is primarily attributable to return to accrual adjustments and decreased exempt income of 1.9% and 0.3% respectively, offset by changes in pre-tax income in countries with varying statutory tax rates of 1.6%. Our effective income tax rate for the first nine months of 2022 was 19.3% compared with 17.4% for the first nine months of 2021. In the first nine months of 2021, we benefited from return to accrual adjustments primarily associated with a step-up of certain Italian assets to fair market value and benefits resulting from the Coronavirus Aid, Relief, and Economic Security Act, also known as “CARES Act” of 2.0% and 1.1%, respectively; such benefits did not impact our effective tax rate in the first nine months of 2022. These increases were partially offset by 1.4% decrease in our effective income tax rate due to changes in pre-tax income in countries with varying statutory tax rates.

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Sep. 30, 2022
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies [Text Block]	10. Commitments and Contingencies Commitments —We have various purchase commitments for materials, supplies and services incidental to the ordinary conduct of business, generally for quantities required for our businesses and at prevailing market prices. These commitments are designed to assure sources of supply and are not expected to be in excess of normal requirements. As of September 30, 2022, we had capital expenditure commitments, which we incurred in our normal course of business, including commitments of approximately $137 million related to building our new PO/TBA plant in Houston, Texas. Financial Assurance Instruments —We have obtained letters of credit, performance and surety bonds and have issued financial and performance guarantees to support trade payables, potential liabilities and other obligations. Considering the frequency of claims made against the financial instruments we use to support our obligations, and the magnitude of those financial instruments in light of our current financial position, management does not expect that any claims against or draws on these instruments would have a material adverse effect on our Consolidated Financial Statements. We have not experienced any unmanageable difficulties in obtaining the required financial assurance instruments for our current operations. Environmental Remediation —Our accrued liability for future environmental remediation costs at current and former plant sites and other remediation sites totaled $122 million and $138 million as of September 30, 2022 and December 31, 2021, respectively. At September 30, 2022, the accrued liabilities for individual sites range from less than $1 million to $26 million. The remediation expenditures are expected to occur over a number of years and are not concentrated in any single year. In our opinion, it is reasonably possible that losses in excess of the liabilities recorded may have been incurred. However, we cannot estimate any amount or range of such possible additional losses. New information about sites, new technology or future developments, such as involvement in investigations by regulatory agencies, could require us to reassess our potential exposure related to environmental matters. Indemnification —We are parties to various indemnification arrangements, including arrangements entered into in connection with acquisitions, divestitures and the formation and dissolution of joint ventures. Pursuant to these arrangements, we provide indemnification to and/or receive indemnification from other parties in connection with liabilities that may arise in connection with the transactions and in connection with activities prior to completion of the transactions. These indemnification arrangements typically include provisions pertaining to third-party claims relating to environmental and tax matters and various types of litigation. As of September 30, 2022, we had not accrued any significant amounts for our indemnification obligations, and we are not aware of other circumstances that would likely lead to significant future indemnification obligations. We cannot determine with certainty the potential amount of future payments under the indemnification arrangements until events arise that would trigger a liability under the arrangements. As part of our technology licensing contracts, we give indemnifications to our licensees for liabilities arising from possible patent infringement claims with respect to certain proprietary licensed technologies. Such indemnifications have a stated maximum amount and generally cover a period of 5 to 10 years. Legal Proceedings— We are subject to various lawsuits and claims, including but not limited to, matters involving contract disputes, environmental damages, personal injury and property damage. We vigorously defend ourselves and prosecute these matters as appropriate. Our legal organization applies its knowledge, experience and professional judgment to the specific characteristics of our cases, employing a litigation management process to manage and monitor legal proceedings in which we are a party. Our process facilitates the early evaluation and quantification of potential exposures in individual cases. This process also enables us to track those cases that have been scheduled for trial, mediation or other resolution. We regularly assess the adequacy of legal accruals based on our professional judgment, experience and the information available regarding our cases. Based on consideration of all relevant facts and circumstances, we do not believe the ultimate outcome of any currently pending lawsuit against us will have a material adverse effect upon our operations, financial condition or Consolidated Financial Statements.

Shareholders' Equity and Redeem

Shareholders' Equity and Redeemable Non-controlling Interests	9 Months Ended
	Sep. 30, 2022
Shareholders Equity and Redeemable Non-controlling Interests Abstract [Abstract]
Shareholders' Equity and Redeemable Non-controlling Interests Disclosure [Text Block]	11. Shareholders’ Equity and Redeemable Non-controlling Interests Shareholders’ Equity Dividend Distributions —The following table summarizes the dividends paid in the periods presented, including the special dividend that our board of directors declared in May 2022: Millions of dollars, except per share amounts Dividend Per Aggregate Date of Record March 2022 - Quarterly dividend $ 1.13 $ 371 March 7, 2022 June 2022 - Quarterly dividend 1.19 389 June 6, 2022 June 2022 - Special dividend 5.20 1,704 June 6, 2022 September 2022 - Quarterly dividend 1.19 388 August 29, 2022 $ 8.71 $ 2,852 In addition to the dividends paid to ordinary shareholders above, we paid $7 million of dividend equivalents to holders of restricted stock unit awards during the first nine months of 2022, which are recognized as dividends in Retained earnings. Share Repurchase Authorization —In May 2022, our shareholders approved a proposal to authorize us to repurchase up to 34.0 million ordinary shares, through November 27, 2023 (“2022 Share Repurchase Authorization”), which superseded any prior repurchase authorizations. The timing and amount of these repurchases, which are determined based on our evaluation of market conditions and other factors, may be executed from time to time through open market or privately negotiated transactions. The repurchased shares, which are recorded at cost, are classified as Treasury stock and may be retired or used for general corporate purposes, including for various employee benefit and compensation plans. The following table summarizes our share repurchase activity for the periods presented: Millions of dollars, except shares and per share amounts Shares Average Total Purchase Price, Including For nine months ended September 30, 2022: 2021 Share Repurchase Authorization 2,111,538 $ 97.72 $ 206 2022 Share Repurchase Authorization 2,286,216 87.50 200 4,397,754 $ 92.41 $ 406 For nine months ended September 30, 2021: 2021 Share Repurchase Authorization 953,681 $ 93.34 $ 89 Total cash paid for share repurchases for the nine months ended September 30, 2022 and 2021 was $420 million and $78 million, respectively. Cash payments made during the reporting period may differ from the total purchase price, including commissions and fees, due to the timing of payments. Ordinary Shares —The changes in the outstanding amounts of ordinary shares are as follows: Nine Months Ended 2022 2021 Ordinary shares outstanding: Beginning balance 329,536,389 334,015,220 Share-based compensation 273,943 415,857 Employee stock purchase plan 210,504 149,956 Purchase of ordinary shares (4,397,754) (953,681) Ending balance 325,623,082 333,627,352 Treasury Shares— The changes in the amounts of treasury shares held by the Company are as follows: Nine Months Ended 2022 2021 Ordinary shares held as treasury shares: Beginning balance 10,675,605 6,030,408 Share-based compensation (273,943) (415,857) Employee stock purchase plan — (50,006) Purchase of ordinary shares 4,397,754 953,681 Ending balance 14,799,416 6,518,226 Accumulated Other Comprehensive Loss —The components of, and after-tax changes in, Accumulated other comprehensive loss as of and for the nine months ended September 30, 2022 and 2021 are presented in the following tables: Millions of dollars Financial Defined Benefit Foreign Total Balance – December 31, 2021 $ (354) $ (528) $ (921) $ (1,803) Other comprehensive income (loss) before reclassifications 490 53 (236) 307 Tax expense before reclassifications (113) (12) (119) (244) Amounts reclassified from accumulated other comprehensive loss (219) 121 — (98) Tax (expense) benefit 55 (28) — 27 Net other comprehensive income (loss) 213 134 (355) (8) Balance – September 30, 2022 $ (141) $ (394) $ (1,276) $ (1,811) Millions of dollars Financial Unrealized Defined Benefit Foreign Total Balance – December 31, 2020 $ (426) $ 1 $ (752) $ (766) $ (1,943) Other comprehensive income (loss) before reclassifications 311 (1) — (92) 218 Tax expense before reclassifications (69) — — (35) (104) Amounts reclassified from accumulated other comprehensive loss (142) — 66 — (76) Tax (expense) benefit 32 — (10) — 22 Net other comprehensive income (loss) 132 (1) 56 (127) 60 Balance – September 30, 2021 $ (294) $ — $ (696) $ (893) $ (1,883) The amounts reclassified out of each component of Accumulated other comprehensive loss are as follows: Three Months Ended Nine Months Ended Affected Line Item on Millions of dollars 2022 2021 2022 2021 Reclassification adjustments for: Financial derivatives: Commodities $ (22) $ (14) $ (54) $ (18) Cost of sales Foreign currency (67) (60) (169) (128) Interest expense Interest rates 1 1 4 4 Interest expense Income tax benefit 22 17 55 32 Provision for income taxes Financial derivatives, net of tax (66) (56) (164) (110) Amortization of defined pension items: Settlement loss 6 20 100 24 Other income (expense), net Actuarial loss 5 14 18 40 Other income (expense), net Prior service cost 1 — 3 2 Other income (expense), net Income tax expense (2) (6) (28) (10) Provision for income taxes Defined pension items, net of tax 10 28 93 56 Total reclassifications, before tax (76) (39) (98) (76) Income tax benefit 20 11 27 22 Provision for income taxes Total reclassifications, after tax $ (56) $ (28) $ (71) $ (54) Amount included in net income Redeemable Non-controlling Interests Our redeemable non-controlling interests relate to shares of cumulative perpetual special stock (“redeemable non-controlling interest stock”) issued by a consolidated subsidiary. As of September 30, 2022 and December 31, 2021, we had 113,471 and 115,374 shares of redeemable non-controlling interest stock outstanding, respectively. These shares may be redeemed at any time at the discretion of the holders. During the three and nine months ended September 30, 2022, 1,903 shares were redeemed for approximately $2 million. In February, May and August 2022, we paid cash dividends of $15.00 per share to our redeemable non-controlling interest shareholders of record as of January 15, 2022, April 15, 2022 and July 15, 2022, respectively. Dividends totaled $5 million for each of the nine months ended September 30, 2022 and 2021.

Per Share Data

Per Share Data	9 Months Ended
	Sep. 30, 2022
Earnings Per Share [Abstract]
Per Share Data [Text Block]	12. Per Share Data Basic earnings per share is based upon the weighted average number of shares of common stock outstanding during the period. Diluted earnings per share includes the effect of certain stock option and other equity-based compensation awards. Our unvested restricted stock units contain non-forfeitable rights to dividend equivalents and are considered participating securities. We calculate basic and diluted earnings per share under the two-class method. Earnings per share data is as follows: Three Months Ended September 30, 2022 2021 Millions of dollars Continuing Discontinued Continuing Discontinued Net income (loss) $ 573 $ (1) $ 1,763 $ (1) Dividends on redeemable non-controlling interests (2) — (2) — Net income attributable to participating securities — — (4) — Net income (loss) attributable to ordinary shareholders – basic and diluted $ 571 $ (1) $ 1,757 $ (1) Millions of shares, except per share amounts Basic weighted average common stock outstanding 326 326 334 334 Effect of dilutive securities 1 1 — — Potential dilutive shares 327 327 334 334 Earnings per share: Basic $ 1.75 $ — $ 5.25 $ — Diluted $ 1.75 $ — $ 5.25 $ — Nine Months Ended September 30, 2022 2021 Millions of dollars Continuing Discontinued Continuing Discontinued Net income (loss) $ 3,539 $ (3) $ 4,892 $ (1) Dividends on redeemable non-controlling interests (5) — (5) — Net income attributable to participating securities (9) — (12) — Net income (loss) attributable to ordinary shareholders – basic and diluted $ 3,525 $ (3) $ 4,875 $ (1) Millions of shares, except per share amounts Basic weighted average common stock outstanding 327 327 334 334 Effect of dilutive securities 1 1 — — Potential dilutive shares 328 328 334 334 Earnings per share: Basic $ 10.77 $ (0.01) $ 14.58 $ — Diluted $ 10.75 $ (0.01) $ 14.57 $ —

Segment and Related Information

Segment and Related Information	9 Months Ended
	Sep. 30, 2022
Segment Reporting [Abstract]
Segment and Related Information [Text Block]	13. Segment and Related Information Our operations are managed by senior executives who report to our Chief Executive Officer, the chief operating decision maker. Discrete financial information is available for each of the segments, and our Chief Executive Officer uses the operating results of each of the operating segments for performance evaluation and resource allocation. The activities of each of our segments from which they earn revenues and incur expenses are described below: • Olefins and Polyolefins—Americas (“O&P—Americas”). Our O&P—Americas segment produces and markets olefins and co-products, polyethylene and polypropylene. • Olefins and Polyolefins—Europe, Asia, International (“O&P—EAI”). Our O&P—EAI segment produces and markets olefins and co-products, polyethylene and polypropylene. • Intermediates and Derivatives (“I&D”). Our I&D segment produces and markets propylene oxide and its derivatives, oxyfuels and related products, and intermediate chemicals such as styrene monomer, acetyls, ethylene oxide and ethylene glycol. • Advanced Polymer Solutions (“APS”) . Our APS segment produces and markets compounding and solutions, such as polypropylene compounds, engineered plastics, masterbatches, engineered composites, colors and powders, and advanced polymers, which includes Catalloy and polybutene-1. • Refining . Our Refining segment refines heavy, high-sulfur crude oil and other crude oils of varied types and sources available on the U.S. Gulf Coast into refined products, including gasoline and distillates. • Technology . Our Technology segment develops and licenses chemical and polyolefin process technologies and manufactures and sells polyolefin catalysts. Our chief operating decision maker uses EBITDA as the primary measure for reviewing profitability of our segments, and therefore, we have presented EBITDA for all segments. We define EBITDA as earnings from continuing operations before interest, income taxes, and depreciation and amortization. “Other” includes intersegment eliminations and items that are not directly related or allocated to business operations, such as foreign exchange gains or losses and components of pension and other postretirement benefit costs other than service costs. Sales between segments are made primarily at prices approximating prevailing market prices. Summarized financial information concerning reportable segments is shown in the following tables for the periods presented: Three Months Ended September 30, 2022 Millions of dollars O&P– O&P– I&D APS Refining Technology Other Total Sales and other operating revenues: Customers $ 2,300 $ 2,767 $ 3,229 $ 1,294 $ 2,506 $ 154 $ — $ 12,250 Intersegment 1,266 181 54 — 246 19 (1,766) — 3,566 2,948 3,283 1,294 2,752 173 (1,766) 12,250 Income (loss) from equity investments 19 (39) (6) — — — — (26) EBITDA 559 (83) 360 66 106 92 8 1,108 Capital expenditures 69 52 245 20 22 25 6 439 Three Months Ended September 30, 2021 Millions of dollars O&P– O&P– I&D APS Refining Technology Other Total Sales and other operating revenues: Customers $ 3,071 $ 3,262 $ 2,851 $ 1,280 $ 2,050 $ 186 $ — $ 12,700 Intersegment 1,337 196 43 6 238 52 (1,872) — 4,408 3,458 2,894 1,286 2,288 238 (1,872) 12,700 Income from equity investments 29 66 9 — — — — 104 EBITDA 1,568 474 348 121 41 155 (16) 2,691 Capital expenditures 72 54 327 20 17 22 2 514 Nine Months Ended September 30, 2022 Millions of dollars O&P– O&P– I&D APS Refining Technology Other Total Sales and other operating revenues: Customers $ 7,184 $ 9,786 $ 10,219 $ 4,124 $ 8,467 $ 465 $ — $ 40,245 Intersegment 4,046 638 169 3 793 83 (5,732) — 11,230 10,424 10,388 4,127 9,260 548 (5,732) 40,245 Income (loss) from equity investments 81 (39) (17) — — — — 25 EBITDA 2,375 264 1,581 309 672 307 1 5,509 Capital expenditures 305 250 673 50 48 81 10 1,417 Nine Months Ended September 30, 2021 Millions of dollars O&P– O&P– I&D APS Refining Technology Other Total Sales and other operating revenues: Customers $ 7,770 $ 9,342 $ 7,086 $ 3,882 $ 4,784 $ 479 $ — $ 33,343 Intersegment 3,220 618 160 10 575 107 (4,690) — 10,990 9,960 7,246 3,892 5,359 586 (4,690) 33,343 Income from equity investments 94 263 32 — — — — 389 EBITDA 4,011 1,594 1,126 385 (150) 341 (13) 7,294 Capital expenditures 219 141 717 55 62 64 27 1,285 In April 2022 we announced our decision to cease operation of our Houston Refinery no later than the end of 2023. We determined that exiting the refining business by the end of next year is the best strategic and financial path forward for the company. Our exit of the refining business progresses our decarbonization goals, and the site’s prime location gives us more options for advancing our future strategic objectives, including circularity. In the interim, we will continue serving the fuels market and consider potential alternatives for the site. In connection with the planned exit from the refinery business, we expensed accelerated lease amortization costs and personnel costs of $36 million and $48 million, respectively, during the third quarter of 2022. We also recorded liabilities for asset retirement obligations of $121 million at September 30, 2022. We expect to expense additional costs primarily consisting of accelerated amortization of operating lease assets of approximately $200 million to $300 million, personnel costs of approximately $50 million to $80 million, and other charges of approximately $50 million to $100 million. We intend to proceed with an orderly shut-down and do not expect to recognize these charges all at once, but rather over time. As of September 30, 2022, we had $473 million and $533 million of renewable identification numbers reflected in Prepaid expenses and other current assets and Accrued liabilities, respectively, for our refinery business. In the second quarter of 2022 we sold our ownership interest in our polypropylene manufacturing facility located in Geelong, Australia, LyondellBasell Australia (Holdings) Pty Ltd, for consideration of $38 million. In connection with this sale, we assessed the net assets of the disposal group for impairment and determined that the carrying value exceeded the fair value less costs to sell. As a result, we recognized a non-cash impairment charge in the second quarter of 2022 of $69 million in the operating results of our O&P—EAI segment. The fair value measurement for the disposal group is based on expected consideration and classified as Level 3 within the fair value hierarchy. The charge is reflected as Impairments in our Consolidated Statements of Income. A reconciliation of EBITDA to Income from continuing operations before income taxes is shown in the following table for each of the periods presented: Three Months Ended Nine Months Ended Millions of dollars 2022 2021 2022 2021 EBITDA: Total segment EBITDA $ 1,100 $ 2,707 $ 5,508 $ 7,307 Other EBITDA 8 (16) 1 (13) Less: Depreciation and amortization expense (318) (351) (933) (1,016) Interest expense (70) (126) (202) (366) Add: Interest income 7 1 13 8 Income from continuing operations before income taxes $ 727 $ 2,215 $ 4,387 $ 5,920

Revenues (Tables)

Revenues (Tables)	9 Months Ended
	Sep. 30, 2022
Revenue from Contract with Customer [Abstract]
Disaggregation of revenue [Table Text Block]	Disaggregation of Revenues— The following table presents our revenues disaggregated by key products: Three Months Ended Nine Months Ended Millions of dollars 2022 2021 2022 2021 Sales and other operating revenues: Olefins and co-products $ 1,281 $ 1,453 $ 3,835 $ 3,729 Polyethylene 2,306 2,705 7,714 7,469 Polypropylene 1,466 2,162 5,383 5,876 Propylene oxide and derivatives 721 832 2,537 2,059 Oxyfuels and related products 1,563 1,088 4,370 2,533 Intermediate chemicals 917 910 3,228 2,436 Compounding and solutions 1,049 1,019 3,297 3,134 Advanced polymers 245 261 827 748 Refined products 2,506 2,050 8,467 4,784 Other 196 220 587 575 Total $ 12,250 $ 12,700 $ 40,245 $ 33,343 The following table presents our revenues disaggregated by geography, based upon the location of the customer: Three Months Ended Nine Months Ended Millions of dollars 2022 2021 2022 2021 Sales and other operating revenues: United States $ 5,966 $ 6,387 $ 19,465 $ 16,089 Germany 822 886 2,892 2,585 China 647 572 1,989 1,693 Japan 800 432 1,684 993 Mexico 482 496 1,522 1,133 Italy 387 489 1,426 1,339 France 312 384 1,145 1,040 Poland 270 300 1,039 841 The Netherlands 261 423 995 1,039 Other 2,303 2,331 8,088 6,591 Total $ 12,250 $ 12,700 $ 40,245 $ 33,343

Inventories (Tables)

Inventories (Tables)	9 Months Ended
	Sep. 30, 2022
Inventory Disclosure [Abstract]
Schedule of inventory [Table Text Block]	Inventories consisted of the following components: Millions of dollars September 30, December 31, Finished goods $ 3,287 $ 3,329 Work-in-process 184 178 Raw materials and supplies 1,682 1,394 Total inventories $ 5,153 $ 4,901

Debt (Tables)

Debt (Tables)	9 Months Ended
	Sep. 30, 2022
Debt Disclosure [Abstract]
Schedule of long-term debt [Table Text Block]	Long-term loans, notes and other debt, net of unamortized discount and debt issuance cost, consisted of the following: Millions of dollars September 30, December 31, Senior Notes due 2024, $1,000 million, 5.75% ($1 million of debt issuance cost) $ 774 $ 773 Senior Notes due 2055, $1,000 million, 4.625% ($15 million of discount; $11 million of debt issuance cost) 974 974 Guaranteed Notes due 2027, $300 million, 8.1% 300 300 Issued by LYB International Finance B.V.: Guaranteed Notes due 2023, $750 million, 4.0% ($1 million of discount) 424 423 Guaranteed Notes due 2043, $750 million, 5.25% ($19 million of discount; $6 million of debt issuance cost) 725 724 Guaranteed Notes due 2044, $1,000 million, 4.875% ($10 million of discount; $9 million of debt issuance cost) 981 981 Issued by LYB International Finance II B.V.: Guaranteed Notes due 2026, €500 million, 0.875% ($1 million of discount; $2 million of debt issuance cost) 474 562 Guaranteed Notes due 2027, $1,000 million, 3.5% ($3 million of discount; $2 million of debt issuance cost) 588 631 Guaranteed Notes due 2031, €500 million, 1.625% ($4 million of discount; $3 million of debt issuance cost) 471 558 Issued by LYB International Finance III LLC: Guaranteed Notes due 2025, $500 million, 1.25% ($1 million of discount; $2 million of debt issuance cost) 475 486 Guaranteed Notes due 2030, $500 million, 3.375% ($1 million of debt issuance cost) 119 143 Guaranteed Notes due 2030, $500 million, 2.25% ($3 million of discount; $4 million of debt issuance cost) 468 490 Guaranteed Notes due 2040, $750 million, 3.375% ($2 million of discount; $7 million of debt issuance cost) 741 741 Guaranteed Notes due 2049, $1,000 million, 4.2% ($14 million of discount; $10 million of debt issuance cost) 976 975 Guaranteed Notes due 2050, $1,000 million, 4.2% ($6 million of discount; $10 million of debt issuance cost) 971 981 Guaranteed Notes due 2051, $1,000 million, 3.625% ($2 million of discount; $11 million of debt issuance cost) 892 986 Guaranteed Notes due 2060, $500 million, 3.8% ($4 million of discount; $6 million of debt issuance cost) 480 490 Other 44 34 Total 10,877 11,252 Less current maturities (432) (6) Long-term debt $ 10,445 $ 11,246 Fair value hedging adjustments associated with the fair value hedge accounting of our fixed-for-floating interest rate swaps for the applicable periods are as follows: Gains (Losses) Cumulative Fair Value Three Months Ended Nine Months Ended September 30, December 31, Millions of dollars 2022 2021 2022 2021 2022 2021 Guaranteed Notes due 2025, 1.25% $ 3 $ 1 $ 12 $ 1 $ 14 $ 2 Guaranteed Notes due 2026, 0.875% 3 1 10 2 11 1 Guaranteed Notes due 2027, 3.5% 15 5 44 12 (2) (46) Guaranteed Notes due 2030, 3.375% 8 1 24 (3) 22 (2) Guaranteed Notes due 2030, 2.25% 7 1 23 1 25 2 Guaranteed Notes due 2031, 1.625% 7 — 10 — 10 — Guaranteed Notes due 2050, 4.2% 5 1 10 1 13 3 Guaranteed Notes due 2051, 3.625% 41 — 95 — 95 — Guaranteed Notes due 2060, 3.8% 8 — 10 — 10 — Total $ 97 $ 10 $ 238 $ 14 $ 198 $ (40) Fair value adjustments are recognized in Interest expense in the Consolidated Statements of Income.
Schedule of short-term debt [Table Text Block]	Short-term loans, notes and other debt consisted of the following: Millions of dollars September 30, December 31, U.S. Receivables Facility $ — $ — Commercial paper 300 204 Precious metal financings 131 155 Other 8 3 Total Short-term debt $ 439 $ 362

Financial Instruments and Fai_2

Financial Instruments and Fair Value Measurements (Tables)	9 Months Ended
	Sep. 30, 2022
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Summary of fair value of outstanding financial instruments [Table Text Block]	Financial Instruments Measured at Fair Value on a Recurring Basis —The following table summarizes financial instruments outstanding for the periods presented that are measured at fair value on a recurring basis: September 30, 2022 December 31, 2021 Millions of dollars Notional Amount Fair Value Notional Amount Fair Value Balance Sheet Assets– Derivatives designated as hedges: Commodities $ 35 $ 15 $ 41 $ 24 Prepaid expenses and other current assets Foreign currency 612 144 614 63 Prepaid expenses and other current assets Foreign currency 3,666 396 1,785 43 Other assets Interest rates — 26 — 7 Prepaid expenses and other current assets Interest rates 400 16 300 1 Other assets Derivatives not designated as hedges: Commodities 160 14 221 30 Prepaid expenses and other current assets Commodities 2 — — — Other assets Foreign currency 318 5 34 1 Prepaid expenses and other current assets Non-derivatives: Equity securities — — 9 8 Short-term investments Total $ 5,193 $ 616 $ 3,004 $ 177 Liabilities– Derivatives designated as hedges: Commodities $ 43 $ 4 $ — $ — Accrued liabilities Foreign currency — 23 — 14 Accrued liabilities Foreign currency — — 1,800 99 Other liabilities Interest rates — 15 — 3 Accrued liabilities Interest rates 2,145 237 1,863 280 Other liabilities Derivatives not designated as hedges: Commodities 101 19 24 1 Accrued liabilities Commodities 7 — — — Other liabilities Foreign currency 87 1 188 2 Accrued liabilities Total $ 2,383 $ 299 $ 3,875 $ 399 The financial instruments in the table above are classified as Level 2. We present the gross assets and liabilities of our derivative financial instruments on the Consolidated Balance Sheets.
Schedule of the carrying value and estimated fair value of non-derivative financial instruments [Table Text Block]	Financial Instruments Not Measured at Fair Value on a Recurring Basis —The following table presents the carrying value and estimated fair value of our Short-term precious metal financings and Long-term debt: September 30, 2022 December 31, 2021 Millions of dollars Carrying Fair Carrying Fair Precious metal financings $ 131 $ 126 $ 155 $ 130 Long-term debt 10,420 9,025 11,218 12,756 Total $ 10,551 $ 9,151 $ 11,373 $ 12,886 The financial instruments in the table above are classified as Level 2. Our other financial instruments classified within Current assets and Current liabilities have a short maturity and their carrying value generally approximates fair value.
Summary of commodity derivatives [Table Text Block]	Commodity Prices —The following table presents the notional amounts of our outstanding commodity derivative instruments: September 30, 2022 December 31, 2021 Millions of dollars Notional Amount Notional Amount Maturity Date Derivatives designated as hedges: Cash flow hedges $ 78 $ 41 2022 to 2023 Derivatives not designated as hedges: Commodity contracts 270 245 2022 to 2024
Summary of interest rate derivatives [Table Text Block]	Interest Rates —The following table presents the notional amounts of our outstanding interest rate derivative instruments: September 30, 2022 December 31, 2021 Millions of dollars Notional Amount Notional Amount Maturity Date Cash flow hedges $ 400 $ 1,000 2024 Fair value hedges 2,145 1,163 2025 to 2031 As of December 31, 2021, Other assets included $238 million of collateral related to forward-starting interest swaps. As of September 30, 2022, there was no collateral remaining as it had been returned.
Summary of foreign currency hedges [Table Text Block]	Foreign Currency Rates —The following table presents the notional amounts of our outstanding foreign currency derivative instruments: September 30, 2022 December 31, 2021 Millions of dollars Notional Amount Notional Amount Maturity Date Net investment hedges $ 3,128 $ 3,048 2023 to 2030 Cash flow hedges 1,150 1,150 2024 to 2027 Not designated 405 222 2022 to 2023
Summary of the impact of financial instruments on earnings and other comprehensive income [Table Text Block]	Impact on Earnings and Other Comprehensive Income —The following tables summarize the pre-tax effect of derivative instruments recorded in Accumulated other comprehensive loss (“AOCI”), the gains (losses) reclassified from AOCI to earnings and additional gains (losses) recognized directly in earnings: Effects of Financial Instruments Three Months Ended September 30, Balance Sheet Income Statement Gain (Loss) Gain (Loss) Reclassified Additional Gain Income Statement Millions of dollars 2022 2021 2022 2021 2022 2021 Classification Derivatives designated as hedges: Commodities $ 10 $ 38 $ (22) $ (14) $ — $ — Cost of sales Foreign currency 285 135 (67) (60) 20 9 Interest expense Interest rates 29 17 1 1 (94) (5) Interest expense Derivatives not designated as hedges: Commodities — — — — (16) 6 Sales and other operating revenues Commodities — — — — (28) 49 Cost of sales Foreign currency — — — — (15) (32) Other income (expense), net Total $ 324 $ 190 $ (88) $ (73) $ (133) $ 27 Effects of Financial Instruments Nine Months Ended September 30, Balance Sheet Income Statement Gain (Loss) Gain (Loss) Reclassified Additional Gain Income Statement Millions of dollars 2022 2021 2022 2021 2022 2021 Classification Derivatives designated as hedges: Commodities $ 40 $ 67 $ (54) $ (18) $ — $ — Cost of sales Foreign currency 607 274 (169) (128) 51 34 Interest expense Interest rates 287 117 4 4 (221) — Interest expense Derivatives not designated as hedges: Commodities — — — — 66 18 Sales and other operating revenues Commodities — — — — (17) 72 Cost of sales Foreign currency — — — — (54) (61) Other income (expense), net Total $ 934 $ 458 $ (219) $ (142) $ (175) $ 63

Pension Benefits (Tables)

Pension Benefits (Tables)	9 Months Ended
	Sep. 30, 2022
Retirement Benefits [Abstract]
Schedule of the components of net periodic benefit costs (credits) [TableText Block]	Components of net periodic pension costs for our U.S. and non-U.S. plans are as follows: U.S. Plans Three Months Ended Nine Months Ended Millions of dollars 2022 2021 2022 2021 Service cost $ 11 $ 15 $ 37 $ 45 Interest cost 13 9 34 26 Expected return on plan assets (20) (28) (77) (82) Settlement loss 6 20 100 24 Actuarial loss amortization 4 8 16 29 Net periodic benefit costs $ 14 $ 24 $ 110 $ 42 Non-U.S. Plans Three Months Ended Nine Months Ended Millions of dollars 2022 2021 2022 2021 Service cost $ 9 $ 11 $ 28 $ 33 Interest cost 7 5 21 16 Expected return on plan assets (5) (4) (15) (12) Prior service amortization 2 1 3 2 Actuarial loss amortization 2 4 6 12 Net periodic benefit costs $ 15 $ 17 $ 43 $ 51

Shareholders' Equity and Rede_2

Shareholders' Equity and Redeemable Non-controlling Interests, Shareholders' Equity (Tables)	9 Months Ended
	Sep. 30, 2022
Shareholders Equity and Redeemable Non-controlling Interests Abstract [Abstract]
Dividend distributions [Table Text Block]	Dividend Distributions —The following table summarizes the dividends paid in the periods presented, including the special dividend that our board of directors declared in May 2022: Millions of dollars, except per share amounts Dividend Per Aggregate Date of Record March 2022 - Quarterly dividend $ 1.13 $ 371 March 7, 2022 June 2022 - Quarterly dividend 1.19 389 June 6, 2022 June 2022 - Special dividend 5.20 1,704 June 6, 2022 September 2022 - Quarterly dividend 1.19 388 August 29, 2022 $ 8.71 $ 2,852
Schedule of share repurchase authorization [Table Text Block]	The following table summarizes our share repurchase activity for the periods presented: Millions of dollars, except shares and per share amounts Shares Average Total Purchase Price, Including For nine months ended September 30, 2022: 2021 Share Repurchase Authorization 2,111,538 $ 97.72 $ 206 2022 Share Repurchase Authorization 2,286,216 87.50 200 4,397,754 $ 92.41 $ 406 For nine months ended September 30, 2021: 2021 Share Repurchase Authorization 953,681 $ 93.34 $ 89
Schedule of changes in ordinary and treasury shares outstanding during the period [Table Text Block]	Ordinary Shares —The changes in the outstanding amounts of ordinary shares are as follows: Nine Months Ended 2022 2021 Ordinary shares outstanding: Beginning balance 329,536,389 334,015,220 Share-based compensation 273,943 415,857 Employee stock purchase plan 210,504 149,956 Purchase of ordinary shares (4,397,754) (953,681) Ending balance 325,623,082 333,627,352 Treasury Shares— The changes in the amounts of treasury shares held by the Company are as follows: Nine Months Ended 2022 2021 Ordinary shares held as treasury shares: Beginning balance 10,675,605 6,030,408 Share-based compensation (273,943) (415,857) Employee stock purchase plan — (50,006) Purchase of ordinary shares 4,397,754 953,681 Ending balance 14,799,416 6,518,226
Schedule of accumulated other comprehensive income (loss) [Table Text Block]	Accumulated Other Comprehensive Loss —The components of, and after-tax changes in, Accumulated other comprehensive loss as of and for the nine months ended September 30, 2022 and 2021 are presented in the following tables: Millions of dollars Financial Defined Benefit Foreign Total Balance – December 31, 2021 $ (354) $ (528) $ (921) $ (1,803) Other comprehensive income (loss) before reclassifications 490 53 (236) 307 Tax expense before reclassifications (113) (12) (119) (244) Amounts reclassified from accumulated other comprehensive loss (219) 121 — (98) Tax (expense) benefit 55 (28) — 27 Net other comprehensive income (loss) 213 134 (355) (8) Balance – September 30, 2022 $ (141) $ (394) $ (1,276) $ (1,811) Millions of dollars Financial Unrealized Defined Benefit Foreign Total Balance – December 31, 2020 $ (426) $ 1 $ (752) $ (766) $ (1,943) Other comprehensive income (loss) before reclassifications 311 (1) — (92) 218 Tax expense before reclassifications (69) — — (35) (104) Amounts reclassified from accumulated other comprehensive loss (142) — 66 — (76) Tax (expense) benefit 32 — (10) — 22 Net other comprehensive income (loss) 132 (1) 56 (127) 60 Balance – September 30, 2021 $ (294) $ — $ (696) $ (893) $ (1,883)
Reclassification out of accumulated other comprehensive income (loss) [Table Text Block]	The amounts reclassified out of each component of Accumulated other comprehensive loss are as follows: Three Months Ended Nine Months Ended Affected Line Item on Millions of dollars 2022 2021 2022 2021 Reclassification adjustments for: Financial derivatives: Commodities $ (22) $ (14) $ (54) $ (18) Cost of sales Foreign currency (67) (60) (169) (128) Interest expense Interest rates 1 1 4 4 Interest expense Income tax benefit 22 17 55 32 Provision for income taxes Financial derivatives, net of tax (66) (56) (164) (110) Amortization of defined pension items: Settlement loss 6 20 100 24 Other income (expense), net Actuarial loss 5 14 18 40 Other income (expense), net Prior service cost 1 — 3 2 Other income (expense), net Income tax expense (2) (6) (28) (10) Provision for income taxes Defined pension items, net of tax 10 28 93 56 Total reclassifications, before tax (76) (39) (98) (76) Income tax benefit 20 11 27 22 Provision for income taxes Total reclassifications, after tax $ (56) $ (28) $ (71) $ (54) Amount included in net income

Per Share Data (Tables)

Per Share Data (Tables)	9 Months Ended
	Sep. 30, 2022
Earnings Per Share [Abstract]
Schedule of earnings per share, basic and diluted [Table Text Block]	Earnings per share data is as follows: Three Months Ended September 30, 2022 2021 Millions of dollars Continuing Discontinued Continuing Discontinued Net income (loss) $ 573 $ (1) $ 1,763 $ (1) Dividends on redeemable non-controlling interests (2) — (2) — Net income attributable to participating securities — — (4) — Net income (loss) attributable to ordinary shareholders – basic and diluted $ 571 $ (1) $ 1,757 $ (1) Millions of shares, except per share amounts Basic weighted average common stock outstanding 326 326 334 334 Effect of dilutive securities 1 1 — — Potential dilutive shares 327 327 334 334 Earnings per share: Basic $ 1.75 $ — $ 5.25 $ — Diluted $ 1.75 $ — $ 5.25 $ — Nine Months Ended September 30, 2022 2021 Millions of dollars Continuing Discontinued Continuing Discontinued Net income (loss) $ 3,539 $ (3) $ 4,892 $ (1) Dividends on redeemable non-controlling interests (5) — (5) — Net income attributable to participating securities (9) — (12) — Net income (loss) attributable to ordinary shareholders – basic and diluted $ 3,525 $ (3) $ 4,875 $ (1) Millions of shares, except per share amounts Basic weighted average common stock outstanding 327 327 334 334 Effect of dilutive securities 1 1 — — Potential dilutive shares 328 328 334 334 Earnings per share: Basic $ 10.77 $ (0.01) $ 14.58 $ — Diluted $ 10.75 $ (0.01) $ 14.57 $ —

Segment and Related Informati_2

Segment and Related Information (Tables)	9 Months Ended
	Sep. 30, 2022
Segment Reporting [Abstract]
Schedule of segment reporting information, by segment [Table Text Block]	Summarized financial information concerning reportable segments is shown in the following tables for the periods presented: Three Months Ended September 30, 2022 Millions of dollars O&P– O&P– I&D APS Refining Technology Other Total Sales and other operating revenues: Customers $ 2,300 $ 2,767 $ 3,229 $ 1,294 $ 2,506 $ 154 $ — $ 12,250 Intersegment 1,266 181 54 — 246 19 (1,766) — 3,566 2,948 3,283 1,294 2,752 173 (1,766) 12,250 Income (loss) from equity investments 19 (39) (6) — — — — (26) EBITDA 559 (83) 360 66 106 92 8 1,108 Capital expenditures 69 52 245 20 22 25 6 439 Three Months Ended September 30, 2021 Millions of dollars O&P– O&P– I&D APS Refining Technology Other Total Sales and other operating revenues: Customers $ 3,071 $ 3,262 $ 2,851 $ 1,280 $ 2,050 $ 186 $ — $ 12,700 Intersegment 1,337 196 43 6 238 52 (1,872) — 4,408 3,458 2,894 1,286 2,288 238 (1,872) 12,700 Income from equity investments 29 66 9 — — — — 104 EBITDA 1,568 474 348 121 41 155 (16) 2,691 Capital expenditures 72 54 327 20 17 22 2 514 Nine Months Ended September 30, 2022 Millions of dollars O&P– O&P– I&D APS Refining Technology Other Total Sales and other operating revenues: Customers $ 7,184 $ 9,786 $ 10,219 $ 4,124 $ 8,467 $ 465 $ — $ 40,245 Intersegment 4,046 638 169 3 793 83 (5,732) — 11,230 10,424 10,388 4,127 9,260 548 (5,732) 40,245 Income (loss) from equity investments 81 (39) (17) — — — — 25 EBITDA 2,375 264 1,581 309 672 307 1 5,509 Capital expenditures 305 250 673 50 48 81 10 1,417 Nine Months Ended September 30, 2021 Millions of dollars O&P– O&P– I&D APS Refining Technology Other Total Sales and other operating revenues: Customers $ 7,770 $ 9,342 $ 7,086 $ 3,882 $ 4,784 $ 479 $ — $ 33,343 Intersegment 3,220 618 160 10 575 107 (4,690) — 10,990 9,960 7,246 3,892 5,359 586 (4,690) 33,343 Income from equity investments 94 263 32 — — — — 389 EBITDA 4,011 1,594 1,126 385 (150) 341 (13) 7,294 Capital expenditures 219 141 717 55 62 64 27 1,285
Reconciliation of EBITDA to income (loss) from continuing operations before income taxes [Table Text Block]	A reconciliation of EBITDA to Income from continuing operations before income taxes is shown in the following table for each of the periods presented: Three Months Ended Nine Months Ended Millions of dollars 2022 2021 2022 2021 EBITDA: Total segment EBITDA $ 1,100 $ 2,707 $ 5,508 $ 7,307 Other EBITDA 8 (16) 1 (13) Less: Depreciation and amortization expense (318) (351) (933) (1,016) Interest expense (70) (126) (202) (366) Add: Interest income 7 1 13 8 Income from continuing operations before income taxes $ 727 $ 2,215 $ 4,387 $ 5,920

Revenues (Details)

Revenues (Details) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
Contract with customer, liability [Abstract]
Contract with customer liability	$ 179		$ 169
Revenue recognized included in beginning contract liability	Revenue recognized in each reporting period, included in the contract liability balance at the beginning of the period, was immaterial.	Revenue recognized in each reporting period, included in the contract liability balance at the beginning of the period, was immaterial.

Revenues, Key products (Details

Revenues, Key products (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Disaggregation of revenue [Abstract]
Sales and other operating revenues	$ 12,250	$ 12,700	$ 40,245	$ 33,343
Olefins & co-products [Member]
Disaggregation of revenue [Abstract]
Sales and other operating revenues	1,281	1,453	3,835	3,729
Polyethylene [Member]
Disaggregation of revenue [Abstract]
Sales and other operating revenues	2,306	2,705	7,714	7,469
Polypropylene [Member]
Disaggregation of revenue [Abstract]
Sales and other operating revenues	1,466	2,162	5,383	5,876
Propylene oxide and derivatives [Member]
Disaggregation of revenue [Abstract]
Sales and other operating revenues	721	832	2,537	2,059
Oxyfuels and related products [Member]
Disaggregation of revenue [Abstract]
Sales and other operating revenues	1,563	1,088	4,370	2,533
Intermediate chemicals [Member]
Disaggregation of revenue [Abstract]
Sales and other operating revenues	917	910	3,228	2,436
Compounding and solutions [Member]
Disaggregation of revenue [Abstract]
Sales and other operating revenues	1,049	1,019	3,297	3,134
Advanced polymers [Member]
Disaggregation of revenue [Abstract]
Sales and other operating revenues	245	261	827	748
Refined products [Member]
Disaggregation of revenue [Abstract]
Sales and other operating revenues	2,506	2,050	8,467	4,784
Other [Member]
Disaggregation of revenue [Abstract]
Sales and other operating revenues	$ 196	$ 220	$ 587	$ 575

Revenues, Geographic locations

Revenues, Geographic locations (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Disaggregation of revenue [Abstract]
Sales and other operating revenues	$ 12,250	$ 12,700	$ 40,245	$ 33,343
U. S. [Member]
Disaggregation of revenue [Abstract]
Sales and other operating revenues	5,966	6,387	19,465	16,089
Germany [Member]
Disaggregation of revenue [Abstract]
Sales and other operating revenues	822	886	2,892	2,585
China [Member]
Disaggregation of revenue [Abstract]
Sales and other operating revenues	647	572	1,989	1,693
Japan [Member]
Disaggregation of revenue [Abstract]
Sales and other operating revenues	800	432	1,684	993
Mexico [Member]
Disaggregation of revenue [Abstract]
Sales and other operating revenues	482	496	1,522	1,133
Italy [Member]
Disaggregation of revenue [Abstract]
Sales and other operating revenues	387	489	1,426	1,339
France [Member]
Disaggregation of revenue [Abstract]
Sales and other operating revenues	312	384	1,145	1,040
Poland [Member]
Disaggregation of revenue [Abstract]
Sales and other operating revenues	270	300	1,039	841
The Netherlands [Member]
Disaggregation of revenue [Abstract]
Sales and other operating revenues	261	423	995	1,039
Other [Member]
Disaggregation of revenue [Abstract]
Sales and other operating revenues	$ 2,303	$ 2,331	$ 8,088	$ 6,591

Accounts Receivable (Details)

Accounts Receivable (Details) - USD ($) $ in Millions	Sep. 30, 2022	Dec. 31, 2021
Receivables [Abstract]
Allowance for credit losses, receivables	$ 5	$ 6

Inventories (Details)

Inventories (Details) - USD ($) $ in Millions	Sep. 30, 2022	Dec. 31, 2021
Inventory, finished goods, work-in-process, and raw materials and supplies [Abstract]
Finished goods	$ 3,287	$ 3,329
Work-in-process	184	178
Raw materials and supplies	1,682	1,394
Total inventories	$ 5,153	$ 4,901

Debt, Long-term debt (Details)

Debt, Long-term debt (Details) € in Millions, $ in Millions	9 Months Ended
	Sep. 30, 2022 USD ($)	Sep. 30, 2022 EUR (€)	Dec. 31, 2021 USD ($)
Long-term debt [Line Items]
Long-term debt	$ 10,877		$ 11,252
Current maturities of long-term debt	(432)		(6)
Long-term debt, non-current portion	$ 10,445		11,246
Senior Notes due 2024, $1,000 million, 5.75% ($1 million of debt issuance cost)
Long-term debt [Line Items]
Maturity year	2024
Face amount	$ 1,000
Stated interest rate (in hundredths)	5.75%	5.75%
Unamortized debt issuance cost	$ 1
Long-term debt	$ 774		773
Senior Notes due 2055, $1,000 million, 4.625% ($15 million of discount; $11 million of debt issuance cost)
Long-term debt [Line Items]
Maturity year	2055
Face amount	$ 1,000
Stated interest rate (in hundredths)	4.625%	4.625%
Unamortized discount	$ 15
Unamortized debt issuance cost	11
Long-term debt	$ 974		974
Guaranteed Notes due 2027, $300 million, 8.1%
Long-term debt [Line Items]
Maturity year	2027
Face amount	$ 300
Stated interest rate (in hundredths)	8.10%	8.10%
Long-term debt	$ 300		300
Guaranteed Notes due 2023, $750 million, 4.0% ($1 million of discount) | Subsidiary Issuer, LYB International Finance B.V.
Long-term debt [Line Items]
Maturity year	2023
Face amount	$ 750
Stated interest rate (in hundredths)	4%	4%
Unamortized discount	$ 1
Long-term debt	$ 424		423
Guaranteed Notes due 2043, $750 million, 5.25% ($19 million of discount; $6 million of debt issuance cost) | Subsidiary Issuer, LYB International Finance B.V.
Long-term debt [Line Items]
Maturity year	2043
Face amount	$ 750
Stated interest rate (in hundredths)	5.25%	5.25%
Unamortized discount	$ 19
Unamortized debt issuance cost	6
Long-term debt	$ 725		724
Guaranteed Notes due 2044, $1,000 million, 4.875% ($10 million of discount; $9 million of debt issuance cost) | Subsidiary Issuer, LYB International Finance B.V.
Long-term debt [Line Items]
Maturity year	2044
Face amount	$ 1,000
Stated interest rate (in hundredths)	4.875%	4.875%
Unamortized discount	$ 10
Unamortized debt issuance cost	9
Long-term debt	$ 981		981
Guaranteed Notes due 2026, €500 million, 0.875% ($1 million of discount; $2 million of debt issuance cost) | Subsidiary Issuer, LYB International Finance II B.V.
Long-term debt [Line Items]
Maturity year	2026
Face amount | €		€ 500
Stated interest rate (in hundredths)	0.875%	0.875%
Unamortized discount	$ 1
Unamortized debt issuance cost	2
Long-term debt	$ 474		562
Guaranteed Notes due 2027, $1,000 million, 3.5% ($3 million of discount; $2 million of debt issuance cost) | Subsidiary Issuer, LYB International Finance II B.V.
Long-term debt [Line Items]
Maturity year	2027
Face amount	$ 1,000
Stated interest rate (in hundredths)	3.50%	3.50%
Unamortized discount	$ 3
Unamortized debt issuance cost	2
Long-term debt	$ 588		631
Guaranteed Notes due 2031, €500 million, 1.625% ($4 million of discount; $3 million of debt issuance cost) | Subsidiary Issuer, LYB International Finance II B.V.
Long-term debt [Line Items]
Maturity year	2031
Face amount | €		€ 500
Stated interest rate (in hundredths)	1.625%	1.625%
Unamortized discount	$ 4
Unamortized debt issuance cost	3
Long-term debt	$ 471		558
Guaranteed Notes due 2025, $500 million, 1.25% ($1 million of discount; $2 million of debt issuance cost) | Subsidiary Issuer, LYB International Finance III LLC
Long-term debt [Line Items]
Maturity year	2025
Face amount	$ 500
Stated interest rate (in hundredths)	1.25%	1.25%
Unamortized discount	$ 1
Unamortized debt issuance cost	2
Long-term debt	$ 475		486
Guaranteed Notes due 2030, $500 million, 3.375% ($1 million of debt issuance cost) | Subsidiary Issuer, LYB International Finance III LLC
Long-term debt [Line Items]
Maturity year	2030
Face amount	$ 500
Stated interest rate (in hundredths)	3.375%	3.375%
Unamortized debt issuance cost	$ 1
Long-term debt	$ 119		143
Guaranteed Notes due 2030, $500 million, 2.25% ($3 million of discount; $4 million of debt issuance cost) | Subsidiary Issuer, LYB International Finance III LLC
Long-term debt [Line Items]
Maturity year	2030
Face amount	$ 500
Stated interest rate (in hundredths)	2.25%	2.25%
Unamortized discount	$ 3
Unamortized debt issuance cost	4
Long-term debt	$ 468		490
Guaranteed Notes due 2040, $750 million, 3.375% ($2 million of discount; $7 million of debt issuance cost) | Subsidiary Issuer, LYB International Finance III LLC
Long-term debt [Line Items]
Maturity year	2040
Face amount	$ 750
Stated interest rate (in hundredths)	3.375%	3.375%
Unamortized discount	$ 2
Unamortized debt issuance cost	7
Long-term debt	$ 741		741
Guaranteed Notes due 2049, $1,000 million, 4.2% ($14 million of discount; $10 million of debt issuance cost) | Subsidiary Issuer, LYB International Finance III LLC
Long-term debt [Line Items]
Maturity year	2049
Face amount	$ 1,000
Stated interest rate (in hundredths)	4.20%	4.20%
Unamortized discount	$ 14
Unamortized debt issuance cost	10
Long-term debt	$ 976		975
Guaranteed Notes due 2050, $1,000 million, 4.2% ($6 million of discount; $10 million of debt issuance cost) | Subsidiary Issuer, LYB International Finance III LLC
Long-term debt [Line Items]
Maturity year	2050
Face amount	$ 1,000
Stated interest rate (in hundredths)	4.20%	4.20%
Unamortized discount	$ 6
Unamortized debt issuance cost	10
Long-term debt	$ 971		981
Guaranteed Notes due 2051, $1,000 million, 3.625% ($2 million of discount; $11 million of debt issuance cost) | Subsidiary Issuer, LYB International Finance III LLC
Long-term debt [Line Items]
Maturity year	2051
Face amount	$ 1,000
Stated interest rate (in hundredths)	3.625%	3.625%
Unamortized discount	$ 2
Unamortized debt issuance cost	11
Long-term debt	$ 892		986
Guaranteed Notes due 2060, $500 million, 3.8% ($4 million of discount; $6 million of debt issuance cost) | Subsidiary Issuer, LYB International Finance III LLC
Long-term debt [Line Items]
Maturity year	2060
Face amount	$ 500
Stated interest rate (in hundredths)	3.80%	3.80%
Unamortized discount	$ 4
Unamortized debt issuance cost	6
Long-term debt	480		490
Other long-term debt [Member]
Long-term debt [Line Items]
Long-term debt	$ 44		$ 34

Debt, Description of fair value

Debt, Description of fair value adjustments for senior and guaranteed notes (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
Debt Instrument [Line Items]
Gain (loss) on fair value adjustments of the hedged item related to interest rate swaps	$ 97	$ 10	$ 238	$ 14
Cumulative fair value hedging adjustments included in carrying amount of debt	$ 198		$ 198		$ (40)
Guaranteed Notes due 2025, 1.25% [Member] | Subsidiary Issuer, LYB International Finance III LLC
Debt Instrument [Line Items]
Maturity year			2025
Stated interest rate (in hundredths)	1.25%		1.25%
Gain (loss) on fair value adjustments of the hedged item related to interest rate swaps	$ 3	1	$ 12	1
Cumulative fair value hedging adjustments included in carrying amount of debt	$ 14		$ 14		2
Guaranteed Notes due 2026, 0.875% [Member] | Subsidiary Issuer, LYB International Finance II B.V.
Debt Instrument [Line Items]
Maturity year			2026
Stated interest rate (in hundredths)	0.875%		0.875%
Gain (loss) on fair value adjustments of the hedged item related to interest rate swaps	$ 3	1	$ 10	2
Cumulative fair value hedging adjustments included in carrying amount of debt	$ 11		$ 11		1
Guaranteed Notes due 2027, 3.5% [Member] | Subsidiary Issuer, LYB International Finance II B.V.
Debt Instrument [Line Items]
Maturity year			2027
Stated interest rate (in hundredths)	3.50%		3.50%
Gain (loss) on fair value adjustments of the hedged item related to interest rate swaps	$ 15	5	$ 44	12
Cumulative fair value hedging adjustments included in carrying amount of debt	$ (2)		$ (2)		(46)
Guaranteed Notes due 2030, 3.375% [Member] | Subsidiary Issuer, LYB International Finance III LLC
Debt Instrument [Line Items]
Maturity year			2030
Stated interest rate (in hundredths)	3.375%		3.375%
Gain (loss) on fair value adjustments of the hedged item related to interest rate swaps	$ 8	1	$ 24	(3)
Cumulative fair value hedging adjustments included in carrying amount of debt	$ 22		$ 22		(2)
Guaranteed Notes due 2030, 2.25% [Member] | Subsidiary Issuer, LYB International Finance III LLC
Debt Instrument [Line Items]
Maturity year			2030
Stated interest rate (in hundredths)	2.25%		2.25%
Gain (loss) on fair value adjustments of the hedged item related to interest rate swaps	$ 7	1	$ 23	1
Cumulative fair value hedging adjustments included in carrying amount of debt	$ 25		$ 25		2
Guaranteed Notes due 2031, 1.625% [Member] | Subsidiary Issuer, LYB International Finance II B.V.
Debt Instrument [Line Items]
Maturity year			2031
Stated interest rate (in hundredths)	1.625%		1.625%
Gain (loss) on fair value adjustments of the hedged item related to interest rate swaps	$ 7		$ 10
Cumulative fair value hedging adjustments included in carrying amount of debt	$ 10		$ 10
Guaranteed Notes due 2050, 4.2% [Member] | Subsidiary Issuer, LYB International Finance III LLC
Debt Instrument [Line Items]
Maturity year			2050
Stated interest rate (in hundredths)	4.20%		4.20%
Gain (loss) on fair value adjustments of the hedged item related to interest rate swaps	$ 5	$ 1	$ 10	$ 1
Cumulative fair value hedging adjustments included in carrying amount of debt	$ 13		$ 13		$ 3
Guaranteed Notes due 2051, 3.625%[Member] | Subsidiary Issuer, LYB International Finance III LLC
Debt Instrument [Line Items]
Maturity year			2051
Stated interest rate (in hundredths)	3.625%		3.625%
Gain (loss) on fair value adjustments of the hedged item related to interest rate swaps	$ 41		$ 95
Cumulative fair value hedging adjustments included in carrying amount of debt	$ 95		$ 95
Guaranteed Notes due 2060, 3.8% [Member] | Subsidiary Issuer, LYB International Finance III LLC
Debt Instrument [Line Items]
Maturity year			2060
Stated interest rate (in hundredths)	3.80%		3.80%
Gain (loss) on fair value adjustments of the hedged item related to interest rate swaps	$ 8		$ 10
Cumulative fair value hedging adjustments included in carrying amount of debt	$ 10		$ 10

Debt, Short-term debt (Details)

Debt, Short-term debt (Details) - USD ($) $ in Millions	Sep. 30, 2022	Dec. 31, 2021
Short-term debt [Line Items]
Short-term debt	$ 439	$ 362
U.S. Receivables Facility [Member]
Short-term debt [Line Items]
Short-term debt	0	0
Commercial paper [Member]
Short-term debt [Line Items]
Short-term debt	300	204
Precious metal financings [Member]
Short-term debt [Line Items]
Short-term debt	131	155
Other short-term debt [Member]
Short-term debt [Line Items]
Short-term debt	$ 8	$ 3

Debt, Description of long-term

Debt, Description of long-term debt (Details) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2022	Dec. 31, 2021
Long-term debt [Line Items]
Outstanding borrowings	$ 10,877	$ 11,252
Senior Revolving Credit Facility [Member]
Long-term debt [Line Items]
Maximum borrowing capacity	$ 3,250
Expiration date	November 2026
Maximum allowed letters of credit	$ 200
Additional borrowing capacity, uncommitted loans	$ 1,000
Credit facility description of interest rate	Borrowings under the facility bear interest at either a base rate, LIBOR rate or EURIBOR rate, plus an applicable margin. Additional fees are incurred for the average daily unused commitments.
Outstanding borrowings	$ 0
Outstanding letters of credit	0
Unused availability	$ 2,950

Debt, Description of short-term

Debt, Description of short-term debt (Details) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2022	Dec. 31, 2021
Description of short-term debt [Line Items]
Outstanding short-term borrowings	$ 439
Weighted average interest rate, short-term debt (in hundredths)	3%	0.90%
U.S. Receivables Facility [Member]
Description of short-term debt [Line Items]
Expiration date	June 2024
Maximum borrowing capacity	$ 900
Additional borrowing capacity, uncommitted loans	$ 300
Credit facility description of interest rate	We pay variable interest rates on our secured borrowings. Additional fees are incurred for the average daily unused commitments.
Maximum allowed letters of credit	$ 200
Outstanding short-term borrowings	0
Outstanding letters of credit	0
Unused availability	900
Commercial paper [Member]
Description of short-term debt [Line Items]
Maximum borrowing capacity	2,500
Outstanding short-term borrowings	$ 300
Description of interest rate	Interest rates on commercial paper outstanding are based on the terms of the notes and was 3.35% at September 30, 2022

Debt, Debt discount and issuanc

Debt, Debt discount and issuance costs included in interest expense (Details) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Debt discount and issuance costs [Abstract]
Amortization of debt discounts and debt issuance costs	$ 11	$ 21

Debt, Covenant Compliance (Deta

Debt, Covenant Compliance (Details)	9 Months Ended
	Sep. 30, 2022
Debt Disclosure [Abstract]
Debt instrument, covenant compliance	we are in compliance with our debt covenants

Financial Instruments and Fai_3

Financial Instruments and Fair Value Measurements, Summary of derivative and non-derivative financial instruments outstanding measured at fair value on a recurring basis (Details) - USD ($) $ in Millions	Sep. 30, 2022	Dec. 31, 2021
Derivative and non-derivative assets and liabilities at fair value, net, by balance sheet classification [Abstract]
Notional amount, derivative and non-derivative financial instruments assets	$ 5,193	$ 3,004
Notional amount, derivative and non-derivative financial instruments liabilities	2,383	3,875
Fair value, derivative and non-derivative financial instruments assets	616	177
Fair value, derivative and non-derivative financial instruments liabilities	299	399
Derivative [Member] | Designated as hedges: [Member] | Commodities [Member] | Prepaid expenses and other current assets [Member] | Fair value, inputs, level 2 [Member]
Derivative and non-derivative assets and liabilities at fair value, net, by balance sheet classification [Abstract]
Notional amount, derivative and non-derivative financial instruments assets	35	41
Fair value, derivative and non-derivative financial instruments assets	15	24
Derivative [Member] | Designated as hedges: [Member] | Commodities [Member] | Accrued liabilities [Member] | Fair value, inputs, level 2 [Member]
Derivative and non-derivative assets and liabilities at fair value, net, by balance sheet classification [Abstract]
Notional amount, derivative and non-derivative financial instruments liabilities	43	0
Fair value, derivative and non-derivative financial instruments liabilities	4	0
Derivative [Member] | Designated as hedges: [Member] | Foreign currency [Member] | Prepaid expenses and other current assets [Member] | Fair value, inputs, level 2 [Member]
Derivative and non-derivative assets and liabilities at fair value, net, by balance sheet classification [Abstract]
Notional amount, derivative and non-derivative financial instruments assets	612	614
Fair value, derivative and non-derivative financial instruments assets	144	63
Derivative [Member] | Designated as hedges: [Member] | Foreign currency [Member] | Other assets [Member] | Fair value, inputs, level 2 [Member]
Derivative and non-derivative assets and liabilities at fair value, net, by balance sheet classification [Abstract]
Notional amount, derivative and non-derivative financial instruments assets	3,666	1,785
Fair value, derivative and non-derivative financial instruments assets	396	43
Derivative [Member] | Designated as hedges: [Member] | Foreign currency [Member] | Accrued liabilities [Member] | Fair value, inputs, level 2 [Member]
Derivative and non-derivative assets and liabilities at fair value, net, by balance sheet classification [Abstract]
Notional amount, derivative and non-derivative financial instruments liabilities	0	0
Fair value, derivative and non-derivative financial instruments liabilities	23	14
Derivative [Member] | Designated as hedges: [Member] | Foreign currency [Member] | Other liabilities [Member] | Fair value, inputs, level 2 [Member]
Derivative and non-derivative assets and liabilities at fair value, net, by balance sheet classification [Abstract]
Notional amount, derivative and non-derivative financial instruments liabilities	0	1,800
Fair value, derivative and non-derivative financial instruments liabilities	0	99
Derivative [Member] | Designated as hedges: [Member] | Interest rate contract [Member] | Prepaid expenses and other current assets [Member] | Fair value, inputs, level 2 [Member]
Derivative and non-derivative assets and liabilities at fair value, net, by balance sheet classification [Abstract]
Notional amount, derivative and non-derivative financial instruments assets	0	0
Fair value, derivative and non-derivative financial instruments assets	26	7
Derivative [Member] | Designated as hedges: [Member] | Interest rate contract [Member] | Other assets [Member] | Fair value, inputs, level 2 [Member]
Derivative and non-derivative assets and liabilities at fair value, net, by balance sheet classification [Abstract]
Notional amount, derivative and non-derivative financial instruments assets	400	300
Fair value, derivative and non-derivative financial instruments assets	16	1
Derivative [Member] | Designated as hedges: [Member] | Interest rate contract [Member] | Accrued liabilities [Member] | Fair value, inputs, level 2 [Member]
Derivative and non-derivative assets and liabilities at fair value, net, by balance sheet classification [Abstract]
Notional amount, derivative and non-derivative financial instruments liabilities	0	0
Fair value, derivative and non-derivative financial instruments liabilities	15	3
Derivative [Member] | Designated as hedges: [Member] | Interest rate contract [Member] | Other liabilities [Member] | Fair value, inputs, level 2 [Member]
Derivative and non-derivative assets and liabilities at fair value, net, by balance sheet classification [Abstract]
Notional amount, derivative and non-derivative financial instruments liabilities	2,145	1,863
Fair value, derivative and non-derivative financial instruments liabilities	237	280
Derivative [Member] | Not designated as hedges: [Member] | Commodities [Member] | Prepaid expenses and other current assets [Member] | Fair value, inputs, level 2 [Member]
Derivative and non-derivative assets and liabilities at fair value, net, by balance sheet classification [Abstract]
Notional amount, derivative and non-derivative financial instruments assets	160	221
Fair value, derivative and non-derivative financial instruments assets	14	30
Derivative [Member] | Not designated as hedges: [Member] | Commodities [Member] | Other assets [Member] | Fair value, inputs, level 2 [Member]
Derivative and non-derivative assets and liabilities at fair value, net, by balance sheet classification [Abstract]
Notional amount, derivative and non-derivative financial instruments assets	2	0
Fair value, derivative and non-derivative financial instruments assets	0	0
Derivative [Member] | Not designated as hedges: [Member] | Commodities [Member] | Accrued liabilities [Member] | Fair value, inputs, level 2 [Member]
Derivative and non-derivative assets and liabilities at fair value, net, by balance sheet classification [Abstract]
Notional amount, derivative and non-derivative financial instruments liabilities	101	24
Fair value, derivative and non-derivative financial instruments liabilities	19	1
Derivative [Member] | Not designated as hedges: [Member] | Commodities [Member] | Other liabilities [Member] | Fair value, inputs, level 2 [Member]
Derivative and non-derivative assets and liabilities at fair value, net, by balance sheet classification [Abstract]
Notional amount, derivative and non-derivative financial instruments liabilities	7	0
Fair value, derivative and non-derivative financial instruments liabilities	0	0
Derivative [Member] | Not designated as hedges: [Member] | Foreign currency [Member] | Prepaid expenses and other current assets [Member] | Fair value, inputs, level 2 [Member]
Derivative and non-derivative assets and liabilities at fair value, net, by balance sheet classification [Abstract]
Notional amount, derivative and non-derivative financial instruments assets	318	34
Fair value, derivative and non-derivative financial instruments assets	5	1
Derivative [Member] | Not designated as hedges: [Member] | Foreign currency [Member] | Accrued liabilities [Member] | Fair value, inputs, level 2 [Member]
Derivative and non-derivative assets and liabilities at fair value, net, by balance sheet classification [Abstract]
Notional amount, derivative and non-derivative financial instruments liabilities	87	188
Fair value, derivative and non-derivative financial instruments liabilities	1	2
Non-derivatives: [Member] | Equity securities [Member] | Short-term investments [Member] | Fair value measured at net asset value per share [Member]
Derivative and non-derivative assets and liabilities at fair value, net, by balance sheet classification [Abstract]
Notional amount, derivative and non-derivative financial instruments assets	0	9
Fair value, derivative and non-derivative financial instruments assets	$ 0	$ 8

Financial Instruments and Fai_4

Financial Instruments and Fair Value Measurements, Carrying value and estimated fair value of non-derivative financial instruments (Details) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2022	Dec. 31, 2021
Liabilities: [Abstract]
Precious metal financings, carrying value	$ 439	$ 362
Nonrecurring [Member] | Non-derivatives: [Member]
Liabilities: [Abstract]
Precious metal financings, carrying value	131	155
Long-term debt, carrying value	10,420	11,218
Total liabilities, carrying value	10,551	11,373
Precious metal financings, fair value	126	130
Long-term debt, fair value	9,025	12,756
Total liabilities, fair value	$ 9,151	$ 12,886
Non-derivative fair value level description	The financial instruments in the table above are classified as Level 2

Financial Instruments and Fai_5

Financial Instruments and Fair Value Measurements, Summary of commodity derivatives (Details) - Commodities [Member] - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2022	Dec. 31, 2021
Designated as hedges: [Member] | Cash flow hedging [Member]
Derivative [Line Items]
Notional amount	$ 78	$ 41
Designated as hedges: [Member] | Cash flow hedging [Member] | Minimum [Member]
Derivative [Line Items]
Maturity date	2022
Designated as hedges: [Member] | Cash flow hedging [Member] | Maximum [Member]
Derivative [Line Items]
Maturity date	2023
Not designated as hedges [Member]
Derivative [Line Items]
Notional amount	$ 270	$ 245
Not designated as hedges [Member] | Minimum [Member]
Derivative [Line Items]
Maturity date	2022
Not designated as hedges [Member] | Maximum [Member]
Derivative [Line Items]
Maturity date	2024

Financial Instruments and Fai_6

Financial Instruments and Fair Value Measurements, Summary of interest rate hedges (Details) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2022	Dec. 31, 2021
Cash flow hedge [Member] | Other assets [Member] | Interest rates [Member]
Derivative [Line Items]
Derivative collateral	$ 0	$ 238
Interest rate contract [Member] | Cash flow hedge [Member]
Derivative [Line Items]
Notional amount	$ 400	1,000
Maturity date	2024
Interest rate contract [Member] | Fair value hedge [Member]
Derivative [Line Items]
Notional amount	$ 2,145	$ 1,163
Interest rate contract [Member] | Fair value hedge [Member] | Minimum [Member]
Derivative [Line Items]
Maturity date	2025
Interest rate contract [Member] | Fair value hedge [Member] | Maximum [Member]
Derivative [Line Items]
Maturity date	2031

Financial Instruments and Fai_7

Financial Instruments and Fair Value Measurements, Summary of foreign currency hedges (Details) - Foreign currency [Member] - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2022	Dec. 31, 2021
Designated as hedges: [Member] | Derivative [Member] | Net investment hedges [Member]
Derivative [Line Items]
Notional amount	$ 3,128	$ 3,048
Designated as hedges: [Member] | Derivative [Member] | Net investment hedges [Member] | Minimum [Member]
Derivative [Line Items]
Maturity date	2023
Designated as hedges: [Member] | Derivative [Member] | Net investment hedges [Member] | Maximum [Member]
Derivative [Line Items]
Maturity date	2030
Designated as hedges: [Member] | Derivative [Member] | Cash flow hedging [Member]
Derivative [Line Items]
Notional amount	$ 1,150	1,150
Designated as hedges: [Member] | Derivative [Member] | Cash flow hedging [Member] | Minimum [Member]
Derivative [Line Items]
Maturity date	2024
Designated as hedges: [Member] | Derivative [Member] | Cash flow hedging [Member] | Maximum [Member]
Derivative [Line Items]
Maturity date	2027
Not designated as hedges [Member]
Derivative [Line Items]
Notional amount	$ 405	$ 222
Not designated as hedges [Member] | Minimum [Member]
Derivative [Line Items]
Maturity date	2022
Not designated as hedges [Member] | Maximum [Member]
Derivative [Line Items]
Maturity date	2023

Financial Instruments and Fai_8

Financial Instruments and Fair Value Measurements, Pretax effect of derivative instruments charged directly to income (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Derivative Instruments, gain (loss) [Line Items]
Gain (loss) recognized in AOCI	$ 324	$ 190	$ 934	$ 458
Gain (loss) reclassified to income from AOCI	(88)	(73)	(219)	(142)
Additional gain (loss) recognized in income	(133)	27	(175)	63
Interest expense [Member]
Derivative Instruments, gain (loss) [Line Items]
Pre-tax unrealized gain (loss) to be reclassified to earnings over the next twelve months	6		6
Derivatives: [Member] | Designated as hedges: [Member] | Commodities [Member] | Cost of sales [Member]
Derivative Instruments, gain (loss) [Line Items]
Gain (loss) recognized in AOCI	10	38	40	67
Gain (loss) reclassified to income from AOCI	(22)	(14)	(54)	(18)
Additional gain (loss) recognized in income	0	0	0	0
Derivatives: [Member] | Designated as hedges: [Member] | Foreign currency [Member] | Interest expense [Member]
Derivative Instruments, gain (loss) [Line Items]
Gain (loss) recognized in AOCI	285	135	607	274
Gain (loss) reclassified to income from AOCI	(67)	(60)	(169)	(128)
Additional gain (loss) recognized in income	20	9	51	34
Derivatives: [Member] | Designated as hedges: [Member] | Interest rate contract [Member] | Interest expense [Member]
Derivative Instruments, gain (loss) [Line Items]
Gain (loss) recognized in AOCI	29	17	287	117
Gain (loss) reclassified to income from AOCI	1	1	4	4
Additional gain (loss) recognized in income	(94)	(5)	(221)	0
Derivatives: [Member] | Not designated as hedges [Member] | Commodities [Member] | Sales and other operating revenues [Member]
Derivative Instruments, gain (loss) [Line Items]
Gain (loss) recognized in AOCI	0	0	0	0
Gain (loss) reclassified to income from AOCI	0	0	0	0
Additional gain (loss) recognized in income	(16)	6	66	18
Derivatives: [Member] | Not designated as hedges [Member] | Commodities [Member] | Cost of sales [Member]
Derivative Instruments, gain (loss) [Line Items]
Gain (loss) recognized in AOCI	0	0	0	0
Gain (loss) reclassified to income from AOCI	0	0	0	0
Additional gain (loss) recognized in income	(28)	49	(17)	72
Derivatives: [Member] | Not designated as hedges [Member] | Foreign currency [Member] | Other income (expense), net [Member]
Derivative Instruments, gain (loss) [Line Items]
Gain (loss) recognized in AOCI	0	0	0	0
Gain (loss) reclassified to income from AOCI	0	0	0	0
Additional gain (loss) recognized in income	$ (15)	$ (32)	$ (54)	$ (61)

Financial Instruments and Fai_9

Financial Instruments and Fair Value Measurements, Summary of marketable securities (Details) - USD ($) $ in Millions	Sep. 30, 2022	Dec. 31, 2021
Cash and cash equivalents [Abstract]
Amount of marketable securities classified as cash and cash equivalents	$ 1,075	$ 438

Pension Benefits (Details)

Pension Benefits (Details) $ in Millions	3 Months Ended			9 Months Ended
	Sep. 30, 2022 USD ($)	Jun. 30, 2022 USD ($)	Sep. 30, 2021 USD ($)	Sep. 30, 2022 USD ($)	Sep. 30, 2021 USD ($)	May 31, 2022 USD ($) retiree
Pension Plan [Member] | U. S. [Member]
Net periodic pension and other postretirement benefit costs (credits): [Abstract]
Service cost	$ 11		$ 15	$ 37	$ 45
Interest cost	13		9	34	26
Expected return on plan assets	(20)		(28)	(77)	(82)
Settlement loss	6		20	100	24
Actuarial loss amortization	4		8	16	29
Net periodic benefit costs (credits)	14		24	110	42
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Settlement loss	(6)		(20)	(100)	(24)
Pension Plan [Member] | Non-U.S. [Member]
Net periodic pension and other postretirement benefit costs (credits): [Abstract]
Service cost	9		11	28	33
Interest cost	7		5	21	16
Expected return on plan assets	(5)		(4)	(15)	(12)
Prior service cost (benefit) amortization	2		1	3	2
Actuarial loss amortization	2		4	6	12
Net periodic benefit costs (credits)	$ 15		$ 17	$ 43	$ 51
Pension Plans Included As Part of Group Annuity Contract Transfer [Member] | U. S. [Member]
Net periodic pension and other postretirement benefit costs (credits): [Abstract]
Settlement loss		$ 80
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Pension benefit obligation						$ 361
Number of retirees and beneficiaries insurance company is required to pay | retiree						9,000
Settlement loss		$ (80)

Income Taxes (Details)

Income Taxes (Details)	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Effective income tax rate reconciliation, percent [Abstract]
Effective income tax rate (in hundredths)	21.20%	20.40%	19.30%	17.40%
Income tax benefit [Abstract]
Return to accrual adjustments tax benefit, percent	1.90%		2%
Tax exempt income tax benefit, percent	0.30%
CARES Act tax benefit, percent			1.10%
Varying statutory tax rates, percent	(1.60%)		(1.40%)

Commitments and Contingencies (

Commitments and Contingencies (Details) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2022	Dec. 31, 2021
Commitments and Contingencies Disclosure [Abstract]
Capital expenditure commitments	$ 137
Site contingency [Line Items]
Future environmental remediation costs	$ 122	$ 138
Minimum [Member]
Site contingency [Line Items]
Minimum accrued liability for individual site range	less than $1 million
Maximum [Member]
Site contingency [Line Items]
Maximum accrued liability for individual site range	$ 26

Commitments and Contingencies,

Commitments and Contingencies, Indemnification (Details)	9 Months Ended
	Sep. 30, 2022
Minimum [Member]
Loss Contingencies [Line Items]
Technology licensing contracts indemnification period	5 years
Maximum [Member]
Loss Contingencies [Line Items]
Technology licensing contracts indemnification period	10 years

Shareholders' Equity and Rede_3

Shareholders' Equity and Redeemable Non-controlling Interests, Shareholders' Equity, Dividend distributions (Details) - USD ($) $ / shares in Units, $ in Millions	1 Months Ended			9 Months Ended
	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Sep. 30, 2022
Dividend Paid [Member]
Dividends Payable [Line Items]
Dividend per ordinary share (per share)				$ 8.71
Aggregate dividends paid				$ 2,852
Mar 2022 Quarterly dividend [Member]
Dividends Payable [Line Items]
Dividend per ordinary share (per share)			$ 1.13
Aggregate dividends paid			$ 371
Date of record			Mar. 07, 2022
Jun 2022 Quarterly dividend [Member]
Dividends Payable [Line Items]
Dividend per ordinary share (per share)		$ 1.19
Aggregate dividends paid		$ 389
Date of record		Jun. 06, 2022
Jun 2022 Special dividend [Member]
Dividends Payable [Line Items]
Dividend per ordinary share (per share)		$ 5.20
Aggregate dividends paid		$ 1,704
Date of record		Jun. 06, 2022
Sep 2022 Quarterly dividend [Member]
Dividends Payable [Line Items]
Dividend per ordinary share (per share)	$ 1.19
Aggregate dividends paid	$ 388
Date of record	Aug. 29, 2022
Dividend equivalent [Member]
Dividends Payable [Line Items]
Aggregate dividends paid				$ 7

Shareholders' Equity and Rede_4

Shareholders' Equity and Redeemable Non-controlling Interests, Shareholders' Equity, Share repurchase authorization (Details) - USD ($) $ / shares in Units, $ in Millions	1 Months Ended	9 Months Ended
	May 31, 2022	Sep. 30, 2022	Sep. 30, 2021
Share repurchase authorization [Line Items]
Shares repurchased (in shares)		4,397,754
Average purchase price (in dollars per share)		$ 92.41
Total purchase price, including commissions and fees		$ 406
Cash paid for shares repurchased		$ 420	$ 78
2021 Share Repurchase Authorization [Member]
Share repurchase authorization [Line Items]
Shares repurchased (in shares)		2,111,538	953,681
Average purchase price (in dollars per share)		$ 97.72	$ 93.34
Total purchase price, including commissions and fees		$ 206	$ 89
2022 Share Repurchase Authorization [Member]
Share repurchase authorization [Line Items]
Shares authorized to be repurchased	34,000,000
Share repurchase authorization expiration date	Nov. 27, 2023
Shares repurchased (in shares)		2,286,216
Average purchase price (in dollars per share)		$ 87.50
Total purchase price, including commissions and fees		$ 200

Shareholders' Equity and Rede_5

Shareholders' Equity and Redeemable Non-controlling Interests, Shareholders' Equity, Ordinary shares (Details) - shares	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Ordinary share outstanding [Abstract]
Beginning balance (in shares)	329,536,389
Purchase of ordinary shares (in shares)	(4,397,754)
Ending balance (in shares)	325,623,082
Ordinary shares [Member]
Ordinary share outstanding [Abstract]
Beginning balance (in shares)	329,536,389	334,015,220
Share-based compensation (in shares)	273,943	415,857
Employee stock purchase plan (in shares)	210,504	149,956
Purchase of ordinary shares (in shares)	(4,397,754)	(953,681)
Ending balance (in shares)	325,623,082	333,627,352

Shareholders' Equity and Rede_6

Shareholders' Equity and Redeemable Non-controlling Interests, Shareholders' Equity, Treasury shares (Details) - shares	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Increase (Decrease) in Treasury Stock [Roll Forward]
Beginning balance (in shares)	10,675,605
Purchase of ordinary shares (in shares)	4,397,754
Ending balance (in shares)	14,799,416
Treasury shares [Member]
Increase (Decrease) in Treasury Stock [Roll Forward]
Beginning balance (in shares)	10,675,605	6,030,408
Share-based compensation (in shares)	(273,943)	(415,857)
Employee stock purchase plan (in shares)	0	(50,006)
Purchase of ordinary shares (in shares)	4,397,754	953,681
Ending balance (in shares)	14,799,416	6,518,226

Shareholders' Equity and Rede_7

Shareholders' Equity and Redeemable Non-controlling Interests, Shareholders' Equity, Components of accumulated other comprehensive income (loss) (Details) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Accumulated other comprehensive income (loss) [Line Items]
Accumulated other comprehensive income (loss), beginning of period	$ (1,803)	$ (1,943)
Other comprehensive income (loss) before reclassifications	307	218
Tax (expense) benefit before reclassifications	(244)	(104)
Amounts reclassified from accumulated other comprehensive income (loss)	(98)	(76)
Tax (expense) benefit	27	22
Net other comprehensive income (loss)	(8)	60
Accumulated other comprehensive income (loss), end of period	(1,811)	(1,883)
Financial derivatives [Member]
Accumulated other comprehensive income (loss) [Line Items]
Accumulated other comprehensive income (loss), beginning of period	(354)	(426)
Other comprehensive income (loss) before reclassifications	490	311
Tax (expense) benefit before reclassifications	(113)	(69)
Amounts reclassified from accumulated other comprehensive income (loss)	(219)	(142)
Tax (expense) benefit	55	32
Net other comprehensive income (loss)	213	132
Accumulated other comprehensive income (loss), end of period	(141)	(294)
Unrealized gains (losses) on available-for-sale debt securities [Member]
Accumulated other comprehensive income (loss) [Line Items]
Accumulated other comprehensive income (loss), beginning of period		1
Other comprehensive income (loss) before reclassifications		(1)
Tax (expense) benefit before reclassifications		0
Amounts reclassified from accumulated other comprehensive income (loss)		0
Tax (expense) benefit		0
Net other comprehensive income (loss)		(1)
Accumulated other comprehensive income (loss), end of period		0
Defined benefit pension and other postretirement benefit plans [Member]
Accumulated other comprehensive income (loss) [Line Items]
Accumulated other comprehensive income (loss), beginning of period	(528)	(752)
Other comprehensive income (loss) before reclassifications	53	0
Tax (expense) benefit before reclassifications	(12)	0
Amounts reclassified from accumulated other comprehensive income (loss)	121	66
Tax (expense) benefit	(28)	(10)
Net other comprehensive income (loss)	134	56
Accumulated other comprehensive income (loss), end of period	(394)	(696)
Foreign currency translation adjustments [Member]
Accumulated other comprehensive income (loss) [Line Items]
Accumulated other comprehensive income (loss), beginning of period	(921)	(766)
Other comprehensive income (loss) before reclassifications	(236)	(92)
Tax (expense) benefit before reclassifications	(119)	(35)
Amounts reclassified from accumulated other comprehensive income (loss)	0	0
Tax (expense) benefit	0	0
Net other comprehensive income (loss)	(355)	(127)
Accumulated other comprehensive income (loss), end of period	$ (1,276)	$ (893)

Shareholders' Equity and Rede_8

Shareholders' Equity and Redeemable Non-controlling Interests, Shareholders' Equity, Reclassification out of accumulated other comprehensive income (loss) (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Reclassification adjustments out of accumulated other comprehensive income (loss) [Line Items]
Sales and other operating revenue	$ 12,250	$ 12,700	$ 40,245	$ 33,343
Cost of sales	11,088	10,109	34,491	26,463
Interest expense (income)	70	126	202	366
Income (loss) before income taxes	727	2,215	4,387	5,920
Income tax (expense) benefit	(154)	(452)	(848)	(1,028)
Net income	572	1,762	3,536	4,891
Amounts reclassified out of accumulated other comprehensive income (loss) [Member]
Reclassification adjustments out of accumulated other comprehensive income (loss) [Line Items]
Income (loss) before income taxes	(76)	(39)	(98)	(76)
Income tax (expense) benefit	20	11	27	22
Net income	(56)	(28)	(71)	(54)
Financial derivatives [Member] | Amounts reclassified out of accumulated other comprehensive income (loss) [Member]
Reclassification adjustments out of accumulated other comprehensive income (loss) [Line Items]
Income tax (expense) benefit	22	17	55	32
Net income	(66)	(56)	(164)	(110)
Financial derivatives [Member] | Commodities [Member] | Amounts reclassified out of accumulated other comprehensive income (loss) [Member]
Reclassification adjustments out of accumulated other comprehensive income (loss) [Line Items]
Cost of sales	(22)	(14)	(54)	(18)
Financial derivatives [Member] | Foreign currency [Member] | Amounts reclassified out of accumulated other comprehensive income (loss) [Member]
Reclassification adjustments out of accumulated other comprehensive income (loss) [Line Items]
Interest expense (income)	(67)	(60)	(169)	(128)
Financial derivatives [Member] | Interest rate contract [Member] | Amounts reclassified out of accumulated other comprehensive income (loss) [Member]
Reclassification adjustments out of accumulated other comprehensive income (loss) [Line Items]
Interest expense (income)	1	1	4	4
Amortization of defined pension items [Member] | Amounts reclassified out of accumulated other comprehensive income (loss) [Member]
Reclassification adjustments out of accumulated other comprehensive income (loss) [Line Items]
Settlement (gain) loss	6	20	100	24
Amortization of actuarial (gain) loss	5	14	18	40
Amortization of prior service cost (benefit)	1	0	3	2
Income tax (expense) benefit	(2)	(6)	(28)	(10)
Net income	$ 10	$ 28	$ 93	$ 56

Shareholders' Equity and Rede_9

Shareholders' Equity and Redeemable Non-controlling Interests, Redeemable non-controlling interests (Details) - USD ($) $ / shares in Units, $ in Millions	1 Months Ended			3 Months Ended		9 Months Ended
	Aug. 31, 2022	May 31, 2022	Feb. 28, 2022	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
Temporary Equity [Abstract]
Cumulative redeemable non-controlling interest stock outstanding				113,471		113,471		115,374
Cumulative redeemable non-controlling interest stock redeemed during the period, in shares				1,903		1,903
Cumulative redeemable non-controlling interest stock redeemed during the period, in value				$ 2		$ 2
Redeemable non-controlling interests, dividends per share (in dollars per share)	$ 15	$ 15	$ 15	$ 15	$ 15	$ 45	$ 45
Date of record redeemable non-controlling interest shareholders	Jul. 15, 2022	Apr. 15, 2022	Jan. 15, 2022
Dividends on redeemable non-controlling interests				$ 2	$ 2	$ 5	$ 5

Per Share Data (Details)

Per Share Data (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Earnings per share reconciliation [Abstract]
Net income (loss)	$ 572	$ 1,762	$ 3,536	$ 4,891
Dividends on redeemable non-controlling interests	$ (2)	$ (2)	$ (5)	$ (5)
Earnings per share, Basic [Abstract]
Basic (in dollars per share)	$ 1.75	$ 5.25	$ 10.76	$ 14.58
Earnings per share, Diluted [Abstract]
Diluted (in dollars per share)	$ 1.75	$ 5.25	$ 10.74	$ 14.57
Continuing operations [Member]
Earnings per share reconciliation [Abstract]
Net income (loss)	$ 573	$ 1,763	$ 3,539	$ 4,892
Dividends on redeemable non-controlling interests	(2)	(2)	(5)	(5)
Net (income) loss attributable to participating securities	0	(4)	(9)	(12)
Net income (loss) attributable to ordinary shareholders - Basic	571	1,757	3,525	4,875
Net income (loss) attributable to ordinary shareholders - Diluted	$ 571	$ 1,757	$ 3,525	$ 4,875
Weighted average number of shares outstanding reconciliation [Abstract]
Basic weighted average common stock outstanding (in shares)	326	334	327	334
Effect of dilutive securities: [Abstract]
Effect of dilutive securities (in shares)	1	0	1	0
Potential dilutive shares (in shares)	327	334	328	334
Earnings per share, Basic [Abstract]
Basic (in dollars per share)	$ 1.75	$ 5.25	$ 10.77	$ 14.58
Earnings per share, Diluted [Abstract]
Diluted (in dollars per share)	$ 1.75	$ 5.25	$ 10.75	$ 14.57
Discontinued operations [Member]
Earnings per share reconciliation [Abstract]
Net income (loss)	$ (1)	$ (1)	$ (3)	$ (1)
Dividends on redeemable non-controlling interests	0	0	0	0
Net (income) loss attributable to participating securities	0	0	0	0
Net income (loss) attributable to ordinary shareholders - Basic	(1)	(1)	(3)	(1)
Net income (loss) attributable to ordinary shareholders - Diluted	$ (1)	$ (1)	$ (3)	$ (1)
Weighted average number of shares outstanding reconciliation [Abstract]
Basic weighted average common stock outstanding (in shares)	326	334	327	334
Effect of dilutive securities: [Abstract]
Effect of dilutive securities (in shares)	1	0	1	0
Potential dilutive shares (in shares)	327	334	328	334
Earnings per share, Basic [Abstract]
Basic (in dollars per share)	$ 0	$ 0	$ (0.01)	$ 0
Earnings per share, Diluted [Abstract]
Diluted (in dollars per share)	$ 0	$ 0	$ (0.01)	$ 0

Segment and Related Informati_3

Segment and Related Information (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Summarized financial information concerning reportable segments: [Abstract]
Sales and other operating revenues	$ 12,250	$ 12,700	$ 40,245	$ 33,343
Income (loss) from equity investments	(26)	104	25	389
EBITDA	1,108	2,691	5,509	7,294
Capital expenditures	439	514	1,417	1,285
O&P - Americas [Member]
Summarized financial information concerning reportable segments: [Abstract]
Sales and other operating revenues	2,300	3,071	7,184	7,770
Income (loss) from equity investments	19	29	81	94
EBITDA	559	1,568	2,375	4,011
Capital expenditures	69	72	305	219
O&P - EAI [Member]
Summarized financial information concerning reportable segments: [Abstract]
Sales and other operating revenues	2,767	3,262	9,786	9,342
Income (loss) from equity investments	(39)	66	(39)	263
EBITDA	(83)	474	264	1,594
Capital expenditures	52	54	250	141
I&D [Member]
Summarized financial information concerning reportable segments: [Abstract]
Sales and other operating revenues	3,229	2,851	10,219	7,086
Income (loss) from equity investments	(6)	9	(17)	32
EBITDA	360	348	1,581	1,126
Capital expenditures	245	327	673	717
APS [Member]
Summarized financial information concerning reportable segments: [Abstract]
Sales and other operating revenues	1,294	1,280	4,124	3,882
Income (loss) from equity investments	0	0	0	0
EBITDA	66	121	309	385
Capital expenditures	20	20	50	55
Refining [Member]
Summarized financial information concerning reportable segments: [Abstract]
Sales and other operating revenues	2,506	2,050	8,467	4,784
Income (loss) from equity investments	0	0	0	0
EBITDA	106	41	672	(150)
Capital expenditures	22	17	48	62
Technology [Member]
Summarized financial information concerning reportable segments: [Abstract]
Sales and other operating revenues	154	186	465	479
Income (loss) from equity investments	0	0	0	0
EBITDA	92	155	307	341
Capital expenditures	25	22	81	64
Other [Member]
Summarized financial information concerning reportable segments: [Abstract]
Sales and other operating revenues	0	0	0	0
Income (loss) from equity investments	0	0	0	0
EBITDA	8	(16)	1	(13)
Capital expenditures	6	2	10	27
Intersegment elimination [Member]
Summarized financial information concerning reportable segments: [Abstract]
Sales and other operating revenues	0	0	0	0
Intersegment elimination [Member] | O&P - Americas [Member]
Summarized financial information concerning reportable segments: [Abstract]
Sales and other operating revenues	1,266	1,337	4,046	3,220
Intersegment elimination [Member] | O&P - EAI [Member]
Summarized financial information concerning reportable segments: [Abstract]
Sales and other operating revenues	181	196	638	618
Intersegment elimination [Member] | I&D [Member]
Summarized financial information concerning reportable segments: [Abstract]
Sales and other operating revenues	54	43	169	160
Intersegment elimination [Member] | APS [Member]
Summarized financial information concerning reportable segments: [Abstract]
Sales and other operating revenues	0	6	3	10
Intersegment elimination [Member] | Refining [Member]
Summarized financial information concerning reportable segments: [Abstract]
Sales and other operating revenues	246	238	793	575
Intersegment elimination [Member] | Technology [Member]
Summarized financial information concerning reportable segments: [Abstract]
Sales and other operating revenues	19	52	83	107
Intersegment elimination [Member] | Other [Member]
Summarized financial information concerning reportable segments: [Abstract]
Sales and other operating revenues	(1,766)	(1,872)	(5,732)	(4,690)
Operating segments [Member]
Summarized financial information concerning reportable segments: [Abstract]
Sales and other operating revenues	12,250	12,700	40,245	33,343
Operating segments [Member] | O&P - Americas [Member]
Summarized financial information concerning reportable segments: [Abstract]
Sales and other operating revenues	3,566	4,408	11,230	10,990
Operating segments [Member] | O&P - EAI [Member]
Summarized financial information concerning reportable segments: [Abstract]
Sales and other operating revenues	2,948	3,458	10,424	9,960
Operating segments [Member] | I&D [Member]
Summarized financial information concerning reportable segments: [Abstract]
Sales and other operating revenues	3,283	2,894	10,388	7,246
Operating segments [Member] | APS [Member]
Summarized financial information concerning reportable segments: [Abstract]
Sales and other operating revenues	1,294	1,286	4,127	3,892
Operating segments [Member] | Refining [Member]
Summarized financial information concerning reportable segments: [Abstract]
Sales and other operating revenues	2,752	2,288	9,260	5,359
Operating segments [Member] | Technology [Member]
Summarized financial information concerning reportable segments: [Abstract]
Sales and other operating revenues	173	238	548	586
Operating segments [Member] | Other [Member]
Summarized financial information concerning reportable segments: [Abstract]
Sales and other operating revenues	$ (1,766)	$ (1,872)	$ (5,732)	$ (4,690)

Segment Reporting (Details)

Segment Reporting (Details) - USD ($) $ in Millions	3 Months Ended			9 Months Ended
	Sep. 30, 2022	Jun. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Segment Reporting Information [Line Items]
Impairments	$ 0		$ 0	$ 69	$ 0
O&P - EAI [Member]
Segment Reporting Information [Line Items]
Consideration		$ 38
Impairments		$ 69
Refining [Member]
Segment Reporting Information [Line Items]
Prepaid RINs	473			473
Accrual for RINs current	533			533
Refining [Member] | Accelerated amortization of operating lease assets
Segment Reporting Information [Line Items]
Restructuring and Related Cost, Incurred Cost	36
Refining [Member] | Personnel costs
Segment Reporting Information [Line Items]
Restructuring and Related Cost, Incurred Cost	48
Refining [Member] | Asset Retirement Obligation Costs
Segment Reporting Information [Line Items]
Asset Retirement Obligation, Revision of Estimate	121
Refining [Member] | Minimum [Member] | Accelerated amortization of operating lease assets
Segment Reporting Information [Line Items]
Restructuring and Related Cost, Expected Cost	200			200
Refining [Member] | Minimum [Member] | Personnel costs
Segment Reporting Information [Line Items]
Restructuring and Related Cost, Expected Cost	50			50
Refining [Member] | Minimum [Member] | Other restructuring
Segment Reporting Information [Line Items]
Restructuring and Related Cost, Expected Cost	50			50
Refining [Member] | Maximum [Member] | Accelerated amortization of operating lease assets
Segment Reporting Information [Line Items]
Restructuring and Related Cost, Expected Cost	300			300
Refining [Member] | Maximum [Member] | Personnel costs
Segment Reporting Information [Line Items]
Restructuring and Related Cost, Expected Cost	80			80
Refining [Member] | Maximum [Member] | Other restructuring
Segment Reporting Information [Line Items]
Restructuring and Related Cost, Expected Cost	$ 100			$ 100

Segment and Related Informati_4

Segment and Related Information, Reconciliation of EBITDA to income (loss) from continuing operations before income taxes (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
EBITDA: [Abstract]
Total segment EBITDA	$ 1,100	$ 2,707	$ 5,508	$ 7,307
Other EBITDA	8	(16)	1	(13)
Less: [Abstract]
Depreciation and amortization expense	(318)	(351)	(933)	(1,016)
Interest expense	(70)	(126)	(202)	(366)
Add: [Abstract]
Interest income	7	1	13	8
Income from continuing operations before income taxes	$ 727	$ 2,215	$ 4,387	$ 5,920